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ABSTRACT 
Hypertension is thought to exist in up to five percent of children. A select number of studies have 
investigated the role elevated blood pressure plays in pediatric atherosclerotic progression. 
However these studies contain significant methodological flaws and fail to recognize important 
confounding factors. Therefore, the influence of elevated blood pressure on arterial health in 
children remains to be clearly understood. The purpose of this study was to investigate the 
association between blood pressure (BP) and arterial thickness and stiffuess in children. Common 
carotid artery (CCA) intima-media thickness (IMT) and distensibility (Dist), as well as systemic 
pulse wave velocity (PWV) were measured in 21 elevated blood pressure (EBP; BP ~ 95th 
percentile) and 83 normal blood pressure (NBP; BP < 90th percentile) children 11-14 years of age. 
Both EBP and NBP groups demonstrated BP within the normal clinical range, but EBP showed 
significantly elevated BP as compared to the NBP group. Independent t-tests failed to show 
significant differences between the EBP and NBP groups for CCA IMT (0.43 ± 0.05 mm and 
0.42 ± 0.06 mm, respectively) and Dist (0.0058 ± 0.0024 mmHg-1 and 0.0064 ± 0.0019 mmHil 
respectively). In contrast, a significantly elevated PWV (p<O.OOl) was found in the EBP group 
(423 ± 35 cmls) compared to the NBP group (389 ± 24 cmls). This finding remained constant 
following an analysis of covariance controlling for the effects of maturation, age, sex and obesity. 
This study shows for the first time that children with elevated BP do not have significantly altered 
central arterial structure and function as measured through CCA Dist and IMT, but do possess 
significantly altered systemic arterial stiffuess as measured through PWV. This may be the result 
of sympathetic predominance and its significant influence on the peripheral vasculature. More 
studies are needed to clearly illustrate the temporal sequence of pediatric atherosclerotic 
progression in response to elevated BP. 
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Chapter 1 - Introduction 
1.1 Preamble 
Hypertension is one of the leading risk factors for cardiovascular disease (CVD) in adults (37). 
Twenty-five to 30% of adults are diagnosed with hypertension (42). As for pediatric 
hypertension, estimates range from approximately 1-5% of children (1; 85). However, it is 
thought that pediatric hypertension is largely undiagnosed, hence current estimates are likely 
under-estimated (27). An additional concern is that children with hypertension are likely to 
become hypertensive adults (10). Also, similar to the adult population, children with hypertension 
are more likely to be overweight or obese (99, 100). This is of particular importance considering 
the progressive increase in childhood obesity over the past two decades (46). 
In addition to obesity, current research has shown that children with hypertension are at 
an elevated risk for several other CVD risk factors including elevated low-density lipoprotein 
(LDL), diminished high-density lipoprotein (HDL), and insulin resistance (33). As well, 
hypertension has been linked to physiologic changes that lead to cardiovascular morbidity such as 
left ventricular hypertrophy (42) and diastolic dysfunction (32). Arterial stiffness and thickness 
have been shown to be surrogate markers of atherosclerotic burden (12). Additionally, these 
measures correlate with CVD risk factors and predict CV events in adulthood (28; 55). 
Hypertension in adults has been shown to correlate with arterial stiffness and thickness through a 
number of scientific investigations (5; 35; 48; 79). However, the affect of elevated blood pressure 
(BP) on arterial health in a pediatric population is less understood. In fact, only two studies by 
Litwin and colleagues (50, 51) suggest that arterial thickness and stiffness change in response to 
elevated BP in children. However, these studies contained a number of limitations including a 
limited number of subjects in which both males and females, over a broad age range (6-20 years), 
spanning many pubertal developmental stages and varying body composition profiles were 
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considered, thus making it difficult to determine the influence that elevated BP itself has on 
arterial health in children. Therefore, the objective of this study was to investigate the association 
between elevated BP and arterial health, as measured by central and systemic arterial stiffness 
and central arterial thickness in a child population after controlling for body composition, sex, age 
and maturation. It was hypothesized that a higher arterial stiffness and thickness would exist in 
children with a higher BP compared to those with a lower BP. 
2 
Chapter 2 - Review of Literature 
2.1Arterial System 
The cardiovascular system is comprised of the heart and blood vessels, which are jointly 
responsible for circulating blood throughout the body. The arterial system is responsible for 
carrying blood after ejection from the heart, and transporting it to the capillaries delivering 
oxygen to the working tissue. Arteries are composed of three major layers: the intima layer or 
tunica intema, the tunica media, and the tunica extema or adventitia. The intima is the innermost 
layer that lines the lumen of the artery (34). Several studies have shown the intima to be highly 
involved in the regulation of arterial diameter and elasticity (16; 65). The thick middle layer of 
the artery, known as the media layer, is comprised of smooth muscles, extracellular matrix, and 
elastic fibres. This middle layer responds to incoming signals originating from various sources 
including the intimal layer, liver and autonomic nervous system, in tum causing changes to 
arterial tone. The outermost layer is called the tunica extema/adventitia and primarily consists of 
connective collagen and elastin. The heart ejects blood intermittently at very high pressures, but 
efficient diffusion at the capillaries requires blood to flow slowly at low pressures. In light of this, 
the arteries are highly elastic and effective at cushioning blood flow to reduce pressure and 
provide a constant blood flow throughout the capillaries (69). 
2.2 The Role of Blood Pressure 
Blood pressure generally refers to the pressure exerted on the arterial walls. Systolic blood 
pressure (SBP) is the arterial pressure (mmHg) created by the cardiovascular system during 
ventricular contraction, while diastolic blood pressure (DBP) refers to arterial pressure during 
ventricular relaxation. Systolic blood pressure and DBP pulsate around a mean arterial pressure 
(MAP), which is considered the steady component ofBP and is a product of cardiac output (CO) 
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and total peripheral resistance (TPR) (95). Both SBP and DBP have been investigated 
independently in order to further identify risk factors associated with CVD. Historically, because 
of a poor understanding of cardiovascular disease progression, elevated DBP (which was thought 
to be more associated with arterial peripheral resistance and the actual pressure within the 
vascular network) was implicated as the major predictor of CVD (91). At that time, elevations in 
SBP were correctly interpreted as the consequence of arterial stiffening but the increasing arterial 
stiffness was thought to be a natural aging process and not atherosclerotic progression (91). 
However more recently SBP has been found to be more useful in predicting CVD (91). An 
additional variable which can be obtained from the measurement of BP is pulse pressure (PP) , 
which is simply DBP subtracted from SBP (95). Pulse pressure has been shown to be a powerful 
predictor of CVD risk (18; 79; 81) and for categorizing hypertensive patients at highest risk for 
CVD (57). The following sections will focus on the measurement of BP, as well as a discussion 
of the association between BP and atherosclerosis. 
2.2.1 Measuring Blood Pressure 
Blood pressure is most commonly measured using the auscultatory technique. This technique 
includes occluding the brachial artery using a pressure cuff placed around the upper arm. The cuff 
is then inflated above SBP (30 mmHg above where the palpated radial pulse disappears) and 
gradually decreased while using a stethoscope to listen for pre-determined sounds. The cuff 
pressure at the first Korotkoff sound is used for identifYing SBP and is simply the appearance of a 
clear tapping sound in rhythm with the patient's pulse. Diastolic blood pressure, on the other 
hand, can be recorded at two points during the deflation of the arm cuff. The first option consists 
of recording the cuff pressure during deflation when sounds become muffled and softer, while the 
second and more common technique involves recording the corresponding cuff pressure at the 
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last audible sound as the cuff is deflating (74). For a given individual with SBP equal to 122 
mmHg and DBP 84 mmHg, the BP would be presented as 122/84. The Kortotkoff technique 
requires a highly trained observer, and because of this it is often recorded in a medical setting 
(74). In fact, in order to clinically diagnose hypertension, there must be three consistent elevated 
BP measurements recorded on three separate days (74). For individuals over 18 years of age, 
hypertension is defined as BP above 140/90 mmHg, while pre-hypertension is classified as 
having BP between 139/89 and 120/80 mmHg. Conversely, hypertension in children is defined as 
an average SBP and/or DBP that is ~95th percentile according to sex, age and height guidelines 
developed through the National Health and Nutrition Examination Survey (23), while pre-
hypertension in children is defined as an average SBP and/or DBP that is ~90th percentile, but 
<95th percentile for sex, age and height according to the same NHANES guidelines (23). The data 
used to develop the NHANES percentiles were compiled from a number of large pediatric clinic 
databases (n>80,000) where each subject had BP measured by a physician (auscultatory) on one 
occaSIOn. 
White coat hypertension (WCH), which is defined as elevated BP in a clinical setting but 
normal BP at other times (86), has an estimated prevalence of 10-20%. In light of this, BP 
measurement techniques that require far less training, such as the oscillometric technique, are 
becoming more commonly used in scientific investigations. Oscillometry record oscillations in 
BP from an automated sphygmomanometer cuff estimating SBP and DBP from a derived 
algorithm (61)., Studies have shown that BP values obtained by both auscultatory and 
oscillometric techniques to be comparable (80). 
Another emerging technique for the measurement of BP is 24 hour ambulatory blood 
pressure measurement (ABPM). This method employs portable oscillometric BP measuring 
devices that measure BP at pre-determined time intervals over a 24 hour period (70). The 
advantage of this technique lies in its ability to monitor BP during the sleeping hours, to diagnose 
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silent hypertension and to further avoid misdiagnosing hypertension caused by white coat 
syndrome (70). In adults increasing BP, as measured through ABPM, correlates positively with 
increasing end organ damage (98) and ABPM has been shown to be valuable in the prognosis of 
future CVD events (53). Likewise, when SBP was measured by ABPM in children it was also 
shown to correlate positively with end organ damage, even when casual BP did not (9; 86). 
Although ABPM is becoming more common in pediatric health research, its usefulness is under 
scrutiny because of the lack of reference standards, as well as validity and reliability estimates 
(53). 
2.2.2 Blood pressure and Atherosclerosis 
Elevated BP has been found to be related to increased risk of CVD related morbidity and 
mortality (83). A relationship between increasing BP and coronary heart disease (CHD) was first 
illustrated by epidemiological evidence reported though the ground breaking and extremely 
influential Framingham Study. A major Framingham publication by Kannel and colleagues 
showed that during a 14 year follow-up increasing casual SBP and DBP were related to 
increasing risk of CHD (38). Further supporting this causative relationship, Kannel and 
colleagues (37) showed that after following subjects for 18 years 73% of men and 81% of women 
who had died from CHD had BP > 140/90mmHg. A widely accepted theory as to how 
hypertension detrimentally affects cardiovascular health is through the process of atherosclerosis 
(69; 18). Atherosclerosis is a compound Greek word comprised of atheros, meaning fat 
deposition or paste and sclerosis, which means hardening. Physiologically, this term refers to the 
gradual accumulation of fibrous tissue, cholesterol and calcium in the arterial walls, eventually 
projecting into the lumen in the form of an atheroma (18). Severe atherosclerosis can cause 
arterial occlusion which reduces blood flow and oxygen delivery to tissues downstream. This is 
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known as ischemia. Prolonged occlusion of cerebral arteries often leads to a stroke, while 
occlusion of coronary arteries commonly leads to cardiac myopathy, and in severe cases 
myocardial infarction (18). 
The development of sub-endothelial plaque in the arterial walls is a major component of 
atherosclerosis (5). It is hypothesized that the elevated cyclical stress on the arteries that 
normally accompanies hypertension causes an enlargement of naturally occurring gaps in the 
intima layer (18). This increased space between endothelial cells allows circulating LDL to 
migrate into the sub-endothelial space where they make contact with the media layer. Below the 
intima layer, LDL is susceptible to oxidation by free radicals as well as proteoglycans, which are 
an important component of the extracellular matrix. When oxidized, the modified LDL (mLDL) 
has an inflammatory response releasing cytokines to recruit macrophage migration to the area of 
intimal damage. In tum, the macrophages engulf the mLDL. However, without a negative 
feedback mechanism in place, unregulated mLDL accumulation occurs within the macrophages. 
These engorged macrophages, known as foam cells for their fluffY appearance, contain large 
quantities of lipids which cannot escape back into circulation to be metabolized or re-utilized by 
liver. Eventually, foam cells gather to a point where atherosclerosis can first be clearly viewed in 
the form of a fatty streak, appearing as a yellow smear on the arterial surface (18). The terminal 
point of atherosclerotic progression involves plaque formation. Transition from a fatty streak to 
fibrous plaque involves the migration and proliferation of smooth muscle cells, as well as the 
accumulation of lipids and extracellular matrix within the arterial wall, often with the endpoint of 
arterial occlusion. (18). 
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2.3 Arterial Measures 
Traditionally, invasive techniques requiring arterial catheters such as angiography and more 
recently angioscopy (fibre optic imaging of the inner vessel wall), were employed for 
investigations of arterial adaptations (56). However, recent non-invasive echo-Doppler ultrasound 
techniques have emerged as useful estimators of arterial structure and function (56). This has 
allowed for more widespread arterial investigations which commonly include patients such as 
children, for whom ethical reasons commonly arise when using catheterization for scientific 
endeavours. The following sections will focus on the non-invasive methodology of echo-Doppler 
ultrasound and how it is used to measure arterial structure and function. As well, an overview of 
CV risk factors found to influence arterial structure and function in both adults and children are 
highlighted. 
2.3.1 Echo-Doppler Ultrasound 
Echo-Doppler ultrasound technology allows for the non-invasive visualization of arteries (69). 
The following section will include a discussion the theoretical principles behind Echo-Doppler 
ultrasound as well the limitations of this technology in order to better understand the 
implementation of this equipment into investigations of arterial structure and function. 
2.3.1.1 Principles 
The term "ultrasound" is used to describe any sound which has a frequency above the human 
hearing threshold. The principles behind Echo-Doppler ultrasound are based on the following 
equation: 
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f=c/'A 
According to this formula, f refers to the wave frequency, c is the propagation speed of 
vibration, and 'A is the wave length. The propagation speed, "c", in living tissue is generally 
1.5x105 cm/sec, while the wave length "'A" ranges from 0.08 to 0.016 mm when frequencies (f) 
range from 2 to 10 MHz (69). Attenuation or disruption of the ultrasound vibration intensity can 
result from tissue or scatterers (69). Different tissues can attenuate the ultrasonic vibration in 
specific ways. For example, a small particle such as a red blood cell scatters the signal in all 
directions, whereas a larger interface such as a vessel wall results in a specular reflection of the 
signal (69). Frequency of vibration, homogeneity of the ultrasonic beam, and the absorptive 
properties of the medium all influence attenuation (69). Therefore for best clarity, more 
superficial imaging is done at higher frequencies (5 to 10 MHz), while deeper imaging is done at 
lower frequencies (2 to 4 MHz) (69). 
2.3.1.2 Transducers 
The transducer serves to generate and also detect the reflected ultrasonic signal. It is a central 
component to any ultrasound unit. Ultrasonic frequencies are transmitted poorly through 
materials of low density. Therefore, when transmitting a signal between biological tissue and a 
transducer, a water-based medium or coupling gel is applied between the two surfaces. 
Generally, transducers are comprised of piezoelectric ceramics, which permits them the special 
ability to transform electrical energy into physical or acoustic energy when transmitting the 
ultrasonic signal. In tum when receiving the signal, transform that physical acoustic energy back 
into an electrical signal (69). 
The transducer transmits the ultrasound signal along a beam. The dimensions of the beam 
are a result of the size and shape of the transducer, as well as the frequency of operation. 
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Additionally, the signal received is limited to the properties of the ultrasound beam. Typically, 
beam widths range from 2 to 10 mm (69). 
Two types of transducers exist. The first and simplest type is what is known as a 
continuous wave (CW) transducer. Initially used in the mid 1950s, the CW technique uses two 
separate transducers: one to continually transmit ultrasound vibrations, and the other to 
continually receive reflected (back-scattered) signals (69). CW ultrasound has more accuracy 
when estimating high-velocity blood flow, is relatively in-expensive and has simpler electronic 
circuitry. On the other hand, CW ultrasound lacks depth selectivity which can be disadvantageous 
when working with a large sample volume, and difficult to obtain a desired signal when vessels 
are close together (69). The second type of transducer is pulse-wave (PW). PW ultrasound uses 
only one transducer that serves to both transmit and receive the ultrasonic vibrations. As the name 
suggests, PW uses interrupted pulses of ultrasound (pulse repetition frequency) containing 3- 20 
cycles at a given frequency (69). In order to determine if a signal originated from a fixed depth, 
the PW ultrasound transducer uses a range-gate delay. The number of cycles transmitted and 
time the range-gate is open determines the sample size. As well, beam width of the probe can 
help to determine sampling volume (69). All these characteristics ofPW ultrasound allow for the 
localization of a well-defined source, preventing interference from adjacent vessels or structures. 
Both CW and PW Doppler ultrasound create essentially the same signal. However, since PW has 
the ability to be very selective in what it images, it is the ultrasound of choice for arterial imaging 
(69). 
2.3.1.3 Limitations 
There are several limitations in using Echo-Doppler ultrasound for the purpose of obtaining 
arterial images. Most problems result from technical error, therefore having a skilled operator is 
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very important. First, keeping the probe parallel with the artery allows for consistent, accurate 
analysis of arterial diameter changes across the full cardiac cycle. Second, the operator needs to 
be careful to maintain a minimum hold-down pressure during image collection as this can 
influence the pulsatile changes in vessel diameter over the cardiac cycle and therefore impede 
accurate measurement. Third, electrical noise can be caused from within the Doppler system 
itself, or from external sources. Using high-end equipment can mitigate electrical noise, but there 
is always a baseline level of noise due to thermal effects (69). In fact, an accurate Doppler signal 
relies on a good signal-to-noise ratio, making the choice of probe frequency important; for 
example, high frequencies suffer from severe absorption when being used to image deep vessels, 
increasing the signal-to-noise ratio (69). Understandably, obtaining a clear, crisp image is 
paramount during Echo-Doppler collection for accurate analysis. Attempting to minimize the 
above limitations is essential in order to obtain high quality images. 
2.3.2 Arterial Structure and Function 
Through modem technological advances, Echo-Doppler ultrasound is now a common tool for 
measuring arterial properties such as stiffness and wall thickness. A reduction in arterial stiffness 
is one of the earliest cardiovascular changes to occur in the sequele of atherosclerosis and has 
been shown to be associated with elevated BP, obesity, insulin resistance, and cardiovascular 
morbidity (55). Two major indices of arterial stiffness are arterial distensibility and pulse wave 
velocity (PWV). As mentioned above, a major function of the arterial system is to cushion and 
smooth the turbulent flow of blood ejected from the heart (69). Arterial stiffening not only 
reduces the buffering and smoothing capacity of the arterial wall but often leads to miniscule 
discontinuities in the artery luminal lining allowing LDL migration into the arterial wall initiating 
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atherosclerotic plaque formation (18). For these reasons, both distensibility and PWV have been 
shown to correlate with advancing atherosclerosis and predict future CVD events (5; 6; 11; 81). 
2.3.2.1 Arterial Distensibility and Pulse Wave Velocity 
Arterial distensibility is given by the formula: 
Dist = [(sCSA - dCSA)/dCSA] / (Ps - Pd) 
Where Dist represents distensibility (mmHg-1), sCSA and dSCA equals systolic and 
diastolic arterial cross-sectional area (cm2) respectively, and Ps - Pd represents the pulse pressure 
(mmHg) within the same or comparable vessel. Distensibility is defmed as a relative change in 
vessel diameter/area for a given change in pressure. For example, an elastic and highly distensible 
balloon would expand larger and easier as compared to a very stiff balloon when inflated at 
matching pressure. It is important to note that arterial distensibility can vary within the same 
artery, and between different arteries depending on proximity to vessel branches, and other 
factors (69). 
PWV velocity is given by the formula: 
V=DIT 
Where V denotes velocity (cmls), D equals the estimated distance the blood travels 
between two points (em), and T equals the duration of time required for the pulse wave to travel 
between those two points (s). PWV therefore, is the speed of blood propagation. When the heart 
ejects the contents of the left ventricle into the aorta, a pulse wave is produced that travels 
throughout the arterial system. A healthy and relaxed arterial system propagates the pulse wave 
relatively slowly through the body, whereas a stiffer arterial system that is unable to store 
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pulsatile energy in the distension of the arterial wall can only release the pulse energy in the 
forward plane, resulting in faster pulse propagation speeds. (72). Commonly, PWV is measured 
between the carotid and brachial, carotid and femoral, (72) or femoral and dorsal pedis segments. 
(3). In general, PWV estimates regional arterial stiffuess, whereas Dist describes arterial 
elasticity in a localized arterial section. 
2.3.2.2 Arterial Wall Thickness 
The process of atherosclerosis not only makes the walls of the arteries stiffer, it also makes them 
thicker (71). As shown in Figure 1, a common technique to estimate arterial wall thickness is to 
inspect ultrasound images in order to measure the thickness between the luminal surface of the 
intima and the inner media (IMT) layers (14). 
Art'~W'"'/\. __ A.rte.ry.L.u.m.e.n ______ e~~~~~-__ .·_.~ •. __ ~ _____ _ 
• ~~--~ I -~,--~~~~--
/ ~ 
intima layer ----  intima~media thickness 
media layer-- =:J wall thickness 
Figure 1. Diagram illustrating major arteriallandmarks used for establishing intima-media thickness and 
13 
2.3.3 Arterial Measures in Adults 
Several studies investigating the adult population have shown arterial properties to be influenced 
by advancing age (89), obesity (21), sex (49) and BP (41). A study performed by Stensland-
Bugge et al. measured IMT in 6408 men and women between the ages of 25-84 years (89) and 
found it to be positively related to advancing age. The IMT increase with age, however, was 
greater in men than women. A possible explanation for this lies in an investigation by 
Mendelsohn and colleagues that showed the feminizing hormone estrogen to improve HDLlLDL 
ratio, in turn possibly reducing sub-endothelial tissue accumulation (63). In investigating the 
effect of obesity on arterial stiffness in adults, Danias and colleagues used magnetic resonance 
imaging (MRI) for measurement of aortic elasticity in male participants aged 20-40 years (21). 
They found abdominal aortic elasticity to be decreased in their obese population versus normal 
weight controls (23). Similar findings were found in women by Mizia-Stec et al. who investigated 
the differences in arterial structure and function between 22-obese and 34-normal weight women 
(68). PWV and common carotid artery (CCA) P-stiffness index (an additional measure of arterial 
stiffness) were shown to be elevated in the obese women after matching for SBP and DBP, which 
can also independently alter arterial measures (68). In fact, a comprehensive investigation 
performed by Kovaite and others found that after accounting for many of the risk factors for 
metabolic syndrome in 186 health asymptomatic healthy adults, BP was the most important 
determinant of arterial structure and function as estimated by IMT and PWV (40). According to 
this evidence, it is clear that age, obesity, sex and BP influence arterial thickness and stiffness in 
the adult population. 
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2.3.4 Arterial Measures in Children 
The advent of non-invasive techniques to evaluate arterial health has allowed clinical pediatric 
investigations to become more commonplace. Several studies in children have investigated the 
impact that various factors such as age, maturation, sex and obesity have on arterial structure and 
function (2, 3, 7, 11, 21). However the independent atherosclerotic effect of increased BP is 
difficult to investigate because of its close association with obesity, advancing age, maturity and 
sex. A well designed study with relevant and valid measurement of confounding risk factors is 
needed to clearly demonstrate the independent relationship between BP and atherosclerotic 
progressIOn. 
2.3.4.1 The Effects of Childhood Aging 
Autopsy studies have demonstrated that in all children the process of atherosclerosis is initiated in 
childhood and progresses with age (87). Using non-invasive ultrasound, Tomoko Ishizu et al. 
measured the IMT of 60 healthy children aged 5-14 years with normal serum lipid concentrations 
and BP and showed IMT to increase in a linear manner with increasing age. This effect remained 
after controlling for the influence of sex, obesity, blood lipid profile, parental smoking history 
and BP, hence these authors suggest that the increase in IMT observed in their study was the 
result of normal arterial development and not pathologically exacerbated (31). Likewise, Cheung 
and colleagues investigated arterial stiffness though the measurement of PWV in children aged 6-
18 years. They found after controlling for body height, mass and BP, a significant positive 
relationship between PWV and age existed (19). Another interesting study looking at four age 
groups from childhood to young adulthood (7-14 years, 11-14 years, 15-18 years and 19-22 
years) illustrated that CCA distensibility decreases from childhood to adolescence (47). The 
above studies together imply that in children, advancing age is indeed related to increased arterial 
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wall thickness and stiffuess. Advancing age therefore, is a factor that must be controlled for when 
investigating the independent effect of elevated BP on arterial thickness and stiffuess. 
2.3.4.2 The Effects of Sex 
As in adults, arterial tissue in children is speculated to respond to sex hormones. Puberty is a time 
of rapid hormonal change and peri-pubescent children endure rapid increases in sexualizing 
hormones (29). The hormones most commonly attributed to sexual maturation in males and 
females are testosterone and estrogens respectively, and are thought to have differing effects on 
arterial properties and function (29). Ahimastos et al. published research comparing arterial PWV 
between four groups; pre-pubescent and post pubescent males and females. Before puberty, 
females had significantly elevated central and peripheral PWV as compared to males, indicating 
stiffer arteries. However, post-pubescent females had significantly lower arterial stiffuess than 
their pre-pubescent counterparts, while the opposite was true for males. These changes in PWV 
resulted in no difference between sexes post-puberty (3). Reduced arterial stiffuess in females' 
post-puberty could be the result of estrogens' ability to reduce smooth muscle proliferation (97), 
improve extracellular matrix composition (20) and increase vaso-relaxatory nitric oxide (16). In 
contrast, the increase in arterial stiffuess observed in the post-pubescent males could be the result 
of an increase in testosterone and its' promotion of smooth muscle cell proliferation and 
monocyte adhesion to endothelial cells (62). Evidently, sex is an influential modulator of arterial 
properties in childhood and investigations attempting to measure the influence of risk factors such 
as elevated BP should control for its influence. 
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2.3.4.3 The Effects of Body Composition 
In light of obesity being a known risk factor for CVD in adults and children (44), the relationship 
between increasing adiposity and arterial properties has been investigated in children (24; 30; 39). 
Tounian and colleagues were one of the first investigators to directly investigate arterial estimates 
of atherosclerotic progression in obese children. They found obese children to have significantly 
reduced arterial elasticity and endothelial function, but no difference in IMT (92). In a similar 
follow up study looking at only pre-pubescent obese children, these authors once again showed 
reduced endothelial function as well as arterial elasticity, but no change in IMT (2). Interestingly, 
a study which measured arterial wall thickness in 96 obese and 25 non-obese children aged 9-13 
years showed CCA IMT to be significantly elevated in the obese children (77). This same study 
however also showed that elevated BP and chronic inflammatory markers played a role in the 
IMT difference between groups. Lastly, Mimoun et al. showed that even when looking at only an 
obese popUlation (n=384) of children (age range, 2.5-18 years), the univariate correlation between 
BMI z-score and arterial distensibility was almost significant at a P value of 0.07 (66). It is clear 
based on the literature that obesity plays an important role in the thickening and stiffening of 
arterial tissue in children and is an essential factor that must be measured and controlled for when 
investigating the atherosclerotic effects of other risk factors such as elevated BP. 
2.3.4.4 The Effects of Childhood Blood Pressure 
Although the negative impact of CVD risk factors such as advancing age, obesity and elevated 
BP is well established in adults (18), far less is known about the arterial health of children living 
with the same risk factors. It has been shown through post mortem autopsies that the majority of 
children, and in some cases children as young as 8 years old, have atherosclerotic streaks and that 
they progress in size and frequency with age through adolescence (87). The relative influence of a 
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number of established CVD risk factors on arterial health, such as elevated BP, have yet to be 
elucidated in a childhood population. Using non-invasive techniques such as Echo- Doppler 
ultrasound and PWV, it is now possible to non-invasively study the influence of CVD risk factors 
on arterial health in children. 
In the study by Aggoun and colleagues (2), BP was found to correlate with flow-
mediated dilation, a measure of endothelial dependent dilation in pre-pubescent children aged 7-
9 years. These authors reported that as BP increased, flow-mediated dilation decreased, 
suggesting that elevated BP has a negative impact on endothelial function (2). Similarly, Litwin et 
al. (51) also attempted to investigate the influence BP had on arterial health in children. These 
researchers showed an increased CCA IMT and decreased distensibility in their hypertensive 
population (51). In a follow up study, Litwin and colleagues again illustrated a correlation 
between carotid IMT and BP, specifically SBP and PP (50). Extrapolating results from these 
investigations is difficult however, as the age ranges used were 6-20 years and 5-18 years 
respectively. Causing additional scepticism of their results is the alarming admission that the 
authors were not blinded to the subject's BP status when analyzing arterial images. Echo-Doppler 
arterial analysis is somewhat subjective due to both the choice each operator has on image and 
landmark selection using digital callipers (4). This subjective nature combined with the lack of 
blinding in the aforementioned studies could possibly invalidate their results. (4). 
When using a more narrow age range the relationship between childhood BP and arterial 
health is less clear. Lande et al. investigated arterial parameters of children (age 14.9 ± 2.3 years) 
and showed a significantly elevated CCA IMT in their hypertensive population when matched 
with normotensive children based on BMI (43). However, in a similar study using a population 
on average only one year younger (mean age 13.9 ± 2.9 years), Sorof and colleagues failed to 
show a relationship between BP and carotid IMT, but did show a significant correlation between 
BMI and carotid IMT (85). It is also notable that the aforementioned studies (43; 50; 51) not only 
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didn't control for the effects of maturation and sex, they also used ABMP to measure BP. This 
technique, although gaining popularity, is rarely used in a clinical setting, so there is limited 
relevance of these results to physician guidelines for risk stratification according to a child's 
routine casual BP measurements. 
Pulse wave velocity, a more regional estimate of arterial health is widely used in clinical 
research. A study by Blacher and colleagues revealed that at a given age, PWV is a more 
powerful predictor of atherosclerosis than left ventricular hypertrophy, hypertension, plasma 
lipids and glucose, and smoking duration (11). However, these risk factors are known to be 
clustered in individuals at risk for CVD, suggesting that the PWV predictive power may simply 
be the accumulation of each independent risk factors affect on arterial health and not an 
independent risk of its own. Hence, Li et al. looked at how risk factors measured in asymptomatic 
healthy children related to PWV measured in young adulthood. They concluded that SBP in 
childhood significantly correlated with PWV measured an average of 25 years later (48). To my 
knowledge, a study that investigates the simultaneous relationship between PWV and BP in a 
pediatric population does not exist. 
Therefore, it is apparent due to voids in the literature and prior investigations that the 
relationship between arterial health and BP in a child population is still unknown. This 
information is important not only in that it may aid clinicians in identifying BP profiles that 
suggest elevated atherosclerotic risk, but it will also shed light on the progression of BP 
associated atherosclerosis which may allow for a more focused approach towards combating the 
arterial effects of elevated BP in childhood. The independent effect of BP on arterial 
distensibility, IMT and PWV in children, while controlling for a number of confounding factors 
(i.e. age, sex, maturation, BMI) has yet to be investigated. 
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2.4 Objective 
The purpose of this study was to investigate the relationship between BP and vascular 
characteristics in a pediatric population. 
2.5Hypothesis 
It is expected that children with elevated BP will have reduced arterial stiffness when compared 
to their lower BP counterparts. Additionally, it is hypothesized that arterial wall thickness, as 
estimated by IMT, will be greater in our elevated BP group in comparison to the lower BP 
controls. 
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Chapter 3 - Methods 
3.1 Study design and sample 
The following study was a cross-sectional analysis of children aged 11-14 years carried out in 
accordance to an agreement with the Niagara Catholic District School Board, and was approved 
by the research ethics committee of Brock University (Appendix 1). This agreement allowed 
access to 50 regional schools for the purpose of screening their students for elevated BP. A total 
of 1913 children had their BP assessed in their school environment using the BPM-300 one step 
BP monitor (VSM MedTech Ltd. Coquitlam, BC), which has shown to be highly valid and 
suitable for BP measurements in both adults and children (59). For simplicity, blood pressure was 
consistently measured on the right arm to avoid the effects of coarctation, as well blood pressure 
is not systematically influenced by choosing the dominant or non-dominant arm (74). Cuff size 
was based on arm circumference with at least 80% of the cuffs bladder encircling the arm and a 
cuff width that was at least 40% of mid-arm circumference (93). The inside of the cuff was 
marked with an index and range line. If the index line was not within range, or the cuff size was 
insufficient, the cuff with the appropriate circumference size was chosen. Sizes ranged from 
child, adult small, adult regular, or adult large. Blood pressure was measured following 15 
minutes of relaxed sitting with feet flat on the floor, hand supinated, arm relaxed with the cuff 
positioned at heart level. Six independent sequential measurements were then taken one minute 
apart in accordance with the European Youth Heart Study protocol (78). According to work by 
Graves and colleagues (26), the first measurement was used to familiarize the subjects with cuff 
pressurization and hence was discarded, while the closest 3 measurements out of the remaining 5 
were used to calculate an average BP. Elevated BP (EBP) in children was defmed as BP ;:::95 th, 
moderately elevated BP (MEBP) was ;:::90th percentile and < 95th percentile, while normal BP 
(NBP) was defined as BP<90th percentile for either SBP andlor DBP according to our school 
sample screening results and adjusted for age,. sex and height. Height (cm), sitting height (cm), 
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waist circumference (We; cm), hip circumference (He; cm) and weight (kg) were also measured. 
From this We/He ratio and BMI (kg/m2) were calculated. 
3.2 Laboratory Protocol 
From the total sample of 1913 children, 221 students were selected for laboratory analysis. Based 
on initial field BP measures, there were 71, 47 and 103 students stratified by SBP and/or DBP 
into each of the EBP, MEBP, and NBP groups, respectively. The EBP and MEBP groups 
consisted of all participants that were identified as either EBP or MEBP in the school screen that 
were available for the follow-up laboratory testing, while the NBP group was comprised of 
randomly selected participants. 
Participants were informed of the laboratory testing procedure over the phone before 
consenting and scheduling a testing appointment. Each lab testing session was approximately 90 
minutes and began in the morning with the participants coming into the lab following a 12 hour 
fast. Upon arrival to the laboratory, subjects were provided a more detailed explanation of the 
procedures and were required to sign a consent form. Once consent was obtained, each subject 
provided a pin prick blood drop from the middle finger tip of the non-dominant hand for blood 
lipid screening. Basic anthropometry was measured before the participant was provided with a 
standardized breakfast consisting of a juice box, fruit bar and bagel with either jam or cream 
cheese (~350 kcal). A standard breakfast is important as dietary intake is suspected to have acute 
affects on arterial properties (73). Also, because a full bladder is known to increase sympathetic 
activity (22) and hence BP, participants were encouraged to urinate and then rest for 15 minutes 
in an upright seated position following breakfast. After this point, BP was measured six times 
using the same protocol as in the schools. Following BP measurement, subjects were required to 
lie supine for 15-20 minutes while being prepared for the next procedure. Five minutes of supine 
rest was required in order to record beat-by-beat heart rate (HR) , BP and PWV. As well, an 
22 
additional five minutes of continuous data collection was required to measure carotid artery 
ultrasound images, pulse pressure, and left ventricular imaging. It should be noted that arterial 
analysis was performed as part of a larger study, with several other measures being collected 
during each testing session. The various data collection sessions were temporally sequenced as 
not to influence one another. 
3.3 Laboratory Procedures 
3.3.1 Anthropometry and Pubertal Maturation 
Standing height, sitting height, WC, RC and weight were measured identical to the field testing 
procedures. After removal of footwear, standing height was collected while each subject had their 
back to a stadiometer (Ellard Instrumentation Ltd. Monroe, WA). Each participant was asked to 
perform a deep inhalation and exhalation after which the distance from the ground to a point on 
the wall parallel to the floor on the top of the head was recorded as standing height (0.1 cm). 
Weight (0.1 kg) was recorded with participants wearing shorts and t-shirts using an electronic 
calibrated scale (Zenith, Dalbridge, South Africa). Body mass index (BMI) was then calculated 
using the weight divided by height squared (kg/m2). Sitting height was collected using the same 
stadiometer as standing height. Each subject was asked to sit on a table of which the height was 
known with their back as straight as possible. Sitting height was recorded as the difference 
between recorded height and table height (0.1 cm). Leg length was calculated as the difference 
between standing height and sitting height. 
Pubertal maturation was estimated from measurements of sitting and standing height 
entered into a prediction equation developed by Mirwald and colleagues to differentiate pubertal 
development (67). This variable is referred to as age of peak height velocity (PRV) and represents 
a developmental landmark where the torso is elongating at the same velocity as the legs (8). 
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Therefore, "years from PHV" represents the number of years before (represented in a negative 
number) or after (represented in positive number) PHV occurs, which is roughly at 11 years in 
females and 13 years in males (36) (See Appendix 5 for formula). 
3.3.2 Arterial Distensibility 
Five minutes of beat-by-beat pulse wave data taken from the left middle toe (Pulse Oximeter, PB-
11341031, Nellcor, Boulder, CO) along with a one-lead electrocardiogram (ECG) waveform was 
collected. As well, continuous SBP, DBP and MAP were collected through the use of a Finapres 
(Ohmeda, 2300, Netherlands) positioned at heart level on the left middle finger. Three manual BP 
measurements were also taken on the right arm at the beginning and end of five minutes of 
resting supine data collection. Finapres BP values were adjusted to match manual BP recordings 
to ensure accuracy, after which PP was calculated using both SBP and, DBP (used for the 
calculation of distensibility). Average SBP, DBP, PP, and MAP were calculated from beat-by-
beat data collected during the last minute of the five minute supine rest period. All beat-by-beat 
data was collected using ADInstruments PowerLab Version 5.1 and ADInstruments Chart 5 
Version 5.5.5 (ADIntruments, Colorado Springs, CO). 
Following beat-by-beat data collection, resting central arterial distensibility was 
measured at the CCA. This artery was chosen for its large SIze, easy access, and relative 
simplicity in imaging and analysis compared to other arteries. A minimum of three non-invasive 
imaging sequences consisting of five beat-by-beat diameter changes in the right CCA were 
recorded using Echo-Doppler ultrasound (Vivid i, General Electric Medical Systems, 
Netherlands) from a location approximately 2 cm proximal to the carotid bulb. Simultaneously, 
BP wave contours were collected from the left CCA using a hand-held tonometer (SPT -301, 
Millar Instruments, Houston, TX). The same investigator (who was blinded to the BP and BP 
group of all participants) performed all diameter measurements corresponding to systole (peak of 
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T -wave) and diastole (bottom of S-wave) using the calliper option in the EchoP AC software 
(ECHOPAC7-002308, General Electric Medical Systems, New York). Three diameters from the 
two beat images with the highest clarity (as interpreted by the analyst) within each of the five-
beat recordings were averaged, resulting in an average of 18 measurements for each of diastole 
and systole. Pulsatile cross sectional area (CSA; m2, where r = radius), and the corresponding 
pulsatile pressure was used to determine vessel distensibility using the standard equation: 
Dist (mmHg-l)= [(sCSA - dCSA)/dCSA] / (ps - Pd) 
where sCSA and dCSA represent systolic and diastolic cross-sectional area and Ps and Pd are 
systolic and diastolic Finapres pressures, respectively. Distensibility was used instead of 
compliance in order to control for the influence of BP on resting (diastolic) diameter. As well, 
average finger SBP and DBP were used to calculate distensibility instead of tonometer obtained 
CCA pressure values. Although left CCA PP was obtained using tonometry, it was not used to 
. calculate distensibility due to the fact that it did not consistently meet the criteria of Chen and 
colleagues, who reported the need of a stable baseline, clear maximum amplitude and a 
reasonable configuration in order to accurately estimate intra-arterial pressure changes (17). 
Although finger BP is known to be augmented compared to more central arterial BP (69), it still 
provides the most accurate estimate available of the beat-by-beat difference in PP between the 
groups for this study. 
3.3.3 futima-Media Thickness 
The far wall taken from the top of the ultrasound image had more clarity and therefore was used 
for IMT (mm) measurements. The two highest quality recordings with the three best quality beat 
images were used for IMT measurement. To ensure the lowest possible tension on the arterial 
wall, all measurements were completed during diastole. futima media thickness is the distance 
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between two specific landmarks within the arterial wall measured perpendicular to the 
longitudinal axis of the artery. The first landmark is the luminal surface of the intima layer, while 
the second is the intima-media interface (Figure 1). For each of the two images the common 
carotid artery IMT was measured at three locations along the length of the artery for each of the 
three selected beats. Therefore, reported IMT for each subject was an average of 18 separate 
measures. 
3.3.4 Pulse Wave Velocity 
In order to estimate PWV over a very large systemic region, it was measured by taking the R-
wave of the ECG as the starting point of our pulse wave and using the upstroke of the pulse wave 
taken from the left middle toe as our terminal endpoint. The R-wave of the ECG was used as the 
starting point for its accuracy and simplicity of analysis, while the onset of the pulse wave at the 
toe was used instead of the femoral artery to ensure comfort of our participants. The distance 
between the sternal notch and middle toe was used as the segment length (cm). The PWV 
estimate for each subject was obtained by averaging a total of 15 beats. 
PWV (cmls) = segment length/transit time 
3.4 Reliability Analyses 
In order to test for intra-observer reliability, changes in systolic and diastolic lumen diameters, as 
well as IMT were assessed on two occasions. Images from 20 participants were randomly chosen 
30 days after the initial measurements. Intra-observer reliability of arterial diameter and IMT 
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showed very high intrac1ass correlation coefficients for systolic diameter, diastolic diameter and 
IMT at 0.99, (p<O.OOl), 0.96, (p<0.001), and 0.89 (p<0.01) respectively (Appendix 7). 
3.5 Statistical Analysis 
After obtaining a second automated BP measurement in the laboratory, it was decided that only 
those subjects who consistently remained within the EBP and NBP groups would be analyzed. 
The reasoning behind this stems from the observation that many participants did not stay within 
the same percentile range during laboratory BP collection in comparison to the initial school 
screen, putting the initial categorization of those participants in question. In addition, after 
removing participants that changed BP categories, only 4 participants remained in the MEBP 
group, not enough to use for statistical purposes (Figure 2). Therefore, a total of 21 EBP and 85 
NBP were analyzed and used for statistical comparison. In the case of PWV, a systematic 
methodological oversight resulting in sternal notch-toe segments to not be recorded in several 
participants resulted in PWV being calculated for 71 participants. As for distensibility and IMT, 
attrition was caused by the inability to collect any quality images on one participant and image 
quality being greatly distorted during systole for another participant, leaving us with 104 and 105 
participants to analyze for each of those arterial properties respectively. As for brachial BPs 
reported in this study, they were calculated as the average of the field and lab oscillometric BP 
values. 
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1 st BP Measure (School) 1 
~95th% 95th>x~90th% Random Sample 
2nd BP Measure (Lab) 9~~ 
~95th% 95th>x~90th% <90th% 
n=21 n=4 n=85 
ESP ~ NBP 
Figure 2. Population sample flow chart for EBP (elevated blood pressure), MEBP (moderately elevated 
blood pressure and NBP (normal blood pressure) 
All statistical analyses were carried out using SPSS software version 16.0 for Windows 
(SPSS Inc., Chicago, IL). All variables are reported as mean ± standard deviation and 
significance was set at p::SO.OS. An independent t-test was performed to determine group 
differences for age, height, weight, BMI, PHV, SBP, DBP and MAP, among the EBP and NBP 
group. Additional independent t-tests were performed to evaluate differences in arterial 
characteristics between the EBP and NBP groups. As well, a one-way analysis of covariance 
(ANCOV A) controlling for sex, PHV, age, and BMI were used to determine group differences 
for CCA distensibility, IMT, PP and PWV. Also, correlation analysis was performed with CCA 
distensibility, CCA IMT and PWV as the dependent variables. 
28 
Chapter 4 - Results 
4.1 Anthropometric and Blood Pressure Characteristics 
Anthropometry and BP measurements are shown in Table 1. Significant differences in measures 
of obesity were found between the two groups (p<0.00 1), as well as average SBP (p<O.OO 1), DBP 
(p<0.001) and MAP (p<0.001). No significant differences were found between BP groups for 
PHV (p=0.89), age (p=0.16) or height (p=0.26). 
Table 1. Physical and maturational characteristics of normal blood pressure (NBP) and elevated blood 
pressure (EBP) children 
Demography 
Age (years) 
PHV (yrs from PHV) 
Sex (%male) 
Anthropometry 
Height (cm) 
Weight (kg) 
BMI(kg/m2) 
Blood Pressure 
SBP(mmHg) 
DBP(mmHg) 
MAP (mmHg) 
NBP 
(n=85) 
12.8(0.8) 
-1.71(0.81) 
34 
158.0(9.3) 
46.7(11.6) 
19.8(3.6) 
91(5) 
55(5) 
67(4) 
EBP 
(n=21) 
13.0(0.9) 
-1.68(1.04) 
48 
160.6(9.4) 
65.1(19.6)* 
26.4(7.1)* 
110(6)* 
71(5)* 
84(4)* 
Mean (SD); *Independent t-test p<O.OOI significant difference between groups, PHV=Peak Height 
Velocity, BMI=body mass index, SBP=systolic blood pressure, DBP=diastolic blood pressure, MAP=mean 
arterial pressure. 
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4.2 Arterial Characteristics 
Characteristics of arterial structure and function are shown in Table 2. Independent samples t-
tests showed significant differences in only PWV (cm/sec) (p<O.OOl) and PP (mmHg) (p<O.Ol) 
between NBP and EBP. No significant difference was found between BP groups for any other 
arterial measures (p>0.05). 
Table 2. Arterial characteristics of normal (NBP) and elevated blood pressure (EBP) children 
Arterial Diameters 
SystDiam (mm) 
DiastDiam (mm) 
DiamDiff (mm) 
Arterial Stiffness 
Distensibility (mmHg-1) 
PP(mmHg) 
PWV (cm/sec) 
Arterial Thickness 
IMT(mm) 
NBP 
(n=83) 
5.43(0.43) 
4.83(0.43) 
0.61(0.11) 
0.0064(0.0019) 
44.3(10.8) 
389.2(24.0) (n=57) 
0.42(0.06) (n=84) 
EBP 
(n=21) 
5.6(0.38) 
4.94(0.39) 
0.61(0.11) 
0.0058(0.0024) 
51.8(12.5)* 
423.1(35.0) (n=15)** 
0.43(0.05) 
Mean (SD); Independent t-test *p<O.Ol, **p<O.OOl independent t-test, significant difference between 
groups, SystDiam = arterial diameter during systole of the common carotid artery (CCA), DiastDiam = 
arterial diameter during diastole of the CCA, DiamDiff=SystDiam - DiastDiam, Dist=Distensibility of the 
CCA, PP= Finapres obtained pulse pressure, PWV=Pulse wave velocity, IMT=CCA intima-media 
thickness. 
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4.3 Determinants of Arterial Properties 
Univariate correlations demonstrated that IMT of the common carotid artery was not significantly 
correlated to any of our measured variables ( p>0.05), while CCA distensibility was significantly 
related to PP (p<O.OOl). Further, PWV was significantly related to SBP (p<O.OOl), DBP 
(p<O.OOl), sex (p=0.02), PP (p=O.Ol), BP group (p<O.OOl), BMI (p<O.OOl), and weight (p<0.001) 
(Table 3). 
Table 3. Univariate correlation coefficients (r) between independent (x-axis) and dependent variables (y-axis) 
SBP DBP PP Sex BP Group Weight BMI Age PRV 
(mmHg) (mmHg) (mmHg) (O=f;l=m) (kg) (kg/m2) (years) (years) 
Dist -0.03 -0.09 0.55** -0.12 -0.12 -0.08 -0.01 -0.16 -0.13 
(mmHg-1) 
(n=104) 
PWV 0.59** 0.42** 0.30** 0.28** 0.46** 0.55* 0.55** -0.11 0.07 
(em/sec) 
(n=72) 
IMT 0.09 0.01 0.03 0.01 0.08 0.1 0.11 -0.12 -0.09 
(mm) 
(n=105) 
*p<O.05; **p<O.Ol Dist=distensibility, PWV=pulse wave velocity, IMT=intima-media thickness, SBP=systolic blood 
pressure, DBP=diastolic blood pressure, PP=Finapres obtained pulse pressure, BP Group= blood pressure group, 
BMI=body mass index, PRV=peak height velocity. 
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4.4 Analysis of Covariance 
According to the results of the independent t-tests, no significant differences were found for IMT 
or distensibility between the NBP and EBP groups. For that reason, analysis of co-variation for 
potential confounding factors was not required for IMT or distensibility. However, when the 
difference in PWV between the NBP and EBP groups was adjusted for PHV, BMI, age, and sex, 
a significant difference remained between groups (Table 4). 
Table 4. Adjusted regression analysis for PWV and potential confounding variables between NBP and EBP 
(n=72, ?=O.388) 
Model 
BP Group 
Sex 
BMI 
PHV 
Age 
Unstandardized 
Regression Effect 
20.959 
13.487 
2.042 
6.744 
-4.24 
p-value 
0.013 
0.032 
0.001 
0.289 
0.513 
BP Group=blood pressure group, BMI=body mass index, PHV=peak height velocity, BP group (O=NBP, 
1 =EBP), Sex=% male 
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Chapter 5 - Discussion 
To the author's knowledge, this represents the first investigation to examine the effect of BP on 
both central and systemic arterial characteristics in 11 to 14 year children. The major finding from 
this study was the significant increase in systemic PWV in children with elevated BP, with no 
difference in central arterial IMT or distensibility. 
5.1. The Effect of Blood Pressure 
5.1.1 Systemic Pulse Wave Velocity 
The ability of the arterial system to cushion blood flow ejected from the heart is determined by 
the elasticity of the arterial walls and can be estimated by PWV (52). In an elastic arterial tree, 
transduction of the pulse wave throughout the body is slower compared to a stiffer arterial 
system. Increased PWV has been shown to be strongly correlated to atherosclerosis in both the 
CCA and aorta (96; 81). 
The results of the current study show that children with elevated BP had significantly 
increased systemic arterial stiffness as measured by an 8.7% greater PWV. This difference 
remained after controlling for age, maturation, obesity and sex. As well, PWV was positively 
correlated to SBP, DBP and PP. These findings are not surprising as BP indirectly influences 
PWV. Chronically elevated BP leads to arterial adaptations such as stiffening of vessels, which 
increases pulse wave propagation speed (69). Complicating this issue further, stiffening of arterial 
tissue can elevate SBP and decrease DBP (69). Figure 3 illustrates the interactions between BP, 
PWV and arterial stiffness throughout the vascular system. 
However, the PWV values reported in this study do not match those of other children 
studies. The reason for this discrepancy is due to the different techniques used in the literature 
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(11; 81; 95). The most common method is to calculate the pulse transit time between two specific 
arterial locations. However, the technique used in this study is less common and records the pulse 
transit time from the R -wave of the ECG to the upstroke of the pulse wave contour recorded at 
the toe (45). Thus, the reason the PWV in the present study is slower compared to other studies 
(11) is due to the fact that the current technique incorporates the time it takes for the heart to 
contract and eject the blood. In fact, the commonly used technique for obtaining PWV is to record 
the pulse wave between the carotid and femoral arteries (81). However, our beat-by-beat 
recordings of the pulse wave in the groin area of peri-pubescent children were not a viable option. 
Furthermore, by using a more distal location for terminal pulse wave recordings, both peripheral 
and central vasculature were included, which when compared with CCA distensibility may 
explain the possible differences in arterial stiffness that depend on proximity to the heart. 
Although a study that incorporated our variation of PWV in children does not exist, a publication 
in adult patients with a wide range of BP profiles suffering from systemic lupus (75) showed 
comparable results. 
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Systolic BP Diastolic BP 
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Arterial Stiffness ---~----------------)-'7 Pulse Wave Velocity 
Figure 3. Diagram illustrating interactions between blood pressure and pulse wave velocity. 
Nevertheless, the results of this study are in accordance with a similar investigation by 
Gil et al. who showed a significantly elevated brachial-ankle PWV in hypertensive adolescents 
aged 16-18 years (25). Likewise, Kucerova et al. showed that young normotensive adults (20-30 
years old) with a parental history of hypertension had elevated PWV (carotid to femoral segment) 
when compared to similarly aged adults without parental history of hypertension (41). 
Furthermore, although both groups in Kucerova's study had BP within the normal range, the 
offspring of hypertensive adults had significantly elevated BP (121175 v 114171 mm Hg). This 
suggests that increases in arterial stiffuess may precede chronic hypertension. The current study 
appears to support this theory, as the participants in this study, although significantly younger 
were also not clinically hypertensive and still showed altered systemic PWV. In fact, a study 
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investigating the association between BP and PWV in children after controlling for obesity, age, 
maturation and sex does not exist according to a comprehensive review of the literature (11, 25, 
45, 48, 55). Although the current study did find significant correlations between PWV and BMI, 
weight, height, and sex (Table 3), a significant difference in PWV persisted between NBP and 
EBP groups after simultaneous co-variation of all these potential confounders. This implies that 
BP status has an independent association with peripheral arterial stiffness in children. 
5.1.2 Arterial Intima-Media Thickness 
In the current study, there were no significant differences in CCA IMT between the NBP and 
EBP groups and IMT did not correlate with SBP, DBP or PP. Common carotid artery IMT is a 
common estimate of arterial wall thickness that has been shown to positively correlate with 
atherosclerotic plaque presence (12) and predict future clinical cardiovascular events (28). 
According to the results of this study, the EBP group did not possess a significantly thicker 
arterial wall structure as compared to the NBP group. This is in contrast to that reported by Litwin 
and colleagues (50; 51) who showed both carotid and femoral artery IMT to be significantly 
elevated in their hypertensive population aged 5-20 years. The apparent discrepancy could be due 
to several important differences between studies. First, Litwin and colleagues (50; 51) included a 
wide age spectrum of individuals including infants to young adults. Duration of risk factor 
exposure is known to correlate with advancing atherosclerotic disease (15; 60; 64). Therefore, 
older subjects in Litwin's studies would have naturally been exposed to hypertension much 
longer than younger children, exacerbating the difference between groups in arterial markers. As 
well, aging itself has been shown to have a detrimental effect on arterial thickness (31; 71). 
Second, the BP reported in the current EBP group is relatively low. The two aforementioned 
Litwin publications reported SBP in the children with hypertension to be between 129 and 131 
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mmHg, while the SBP in the EBP group of the current study was only 110 mmHg, with the 
majority of our participants in the EBP group being clinically normotensive (23) . A higher SBP 
would likely lead to an increased IMT, taking into account that SBP is the dominant predictor of 
atherosclerosis (91) and has been shown to relate to IMT even when DBP does not (76). 
However, the current study appears to agree with a study by Stabouli and colleagues that 
investigated carotid IMT in adolescents with normal BP and those with white coat hypertension 
(aged 14 ± 4.5 years) (86). Although both groups were in the normal clinical range during 24-
hour ABPM, the WCH group had significantly elevated BP as compared to the normotensive 
group (118/68 vs.112/65 mmHg) . As well, no difference in IMT was found between BP groups. 
Taking into account Stabouli's results, our study indicates that significant elevations in BP may 
not lead to central arterial atherosclerotic progression in the form of increased CCA IMT, so long 
as BP remains within the clinically accepted normal range. 
5.1.3 Arterial Distensibility 
Distensibility represents the change in vessel diameter for a given change in pressure (34) and 
estimates arterial stiffness in a localized region within the arterial vasculature; commonly the 
CCA (69). Common carotid artery distensibility has been shown to negatively correlate with 
atherosclerotic plaque severity in the CCA as well as the aorta, and predict future CVD (95). In 
this study, differences in CCA distensibility between the NBP (0.0064 ± 0.0019mmHg-1) and 
EBP group (0.0058 ± 0.0024 mmHg -1) were not significant, but are similar to that reported in 
previous work (2). The studies by Litwin and colleagues that report CCA distensibility in children 
with severe hypertension are lower than what was reported in the current study (50; 51). A 
possible explanation for this is that atherosclerotic progression increases with age after puberty 
(71), and that atherosclerosis severity increases with increasing BP (84). Also, CCA distensibility 
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significantly decreases in children/adolescents with increasing age cohorts (11-14 years, 14-17 
years, 17-20 years) (34). In light of this, the differing CCA distensibility between this study and 
Litwin and colleagues (50; 51) is likely due to the wide age ranges used in their studies and the 
aforementioned very high SBP of the children in their hypertensive group. Similar to the IMT 
results, central arterial atherosclerotic progression as estimated through CCA distensibility is 
unaltered in our EBP children. 
5.2 Physiological Implications 
This study showed differing results in arterial elastic measures when using different segments of 
the vasculature for estimation. Systemic arterial stiffness, as measured through PWV, was 
reduced in the EBP group, but central arterial stiffness as measured through CCA distensibility 
was not. It is likely that the differences may, in part, be explained by arterial wall composition 
between central and peripheral arteries. 
It is well established that central arteries are comprised primarily of elastin and contain 
relatively few muscle fibres (58). In contrast, as arteries become more peripheral the relative 
makeup of the arterial wall changes to become more muscular and less elastic (58). In addition, 
when moving from central to more peripheral arteries there is an increase in receptor density of 
adrenergic post-junctional alpha receptors, which respond heavily to sympathetic 
neurotransmitter release (90). Striimper and colleagues have described the primary method by 
which the microvasculature regulates blood flow as receptor activated signalling pathways that 
act to alter arterial diameters, in tum altering resistance to flow (89). For instance, it has been 
shown that the stiffness of muscular conduit vessels (i.e. brachial artery, radial artery) is increased 
during heightened sympathetic nerve activity such as lower body negative pressure and cold 
pressor test (13; 82). As well, Zamir et al. showed that the "lumped" forearm vascular bed had 
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decreased compliance and increased resistance during sympathetic activation (101). In the more 
central carotid artery however, studies have shown increased sympathetic activation having no 
effect on arterial stiffness (54,88). Further, when looking at the proximal and more elastic portion 
of the brachial artery, Bjamegard and colleagues showed no change in stiffness in response to 
lower body negative pressure induced sympathetic activation (7). Indeed this suggests that 
stiffness of the central arteries is less capable of being influenced by sympathetic activation than 
the systemic vasculature. 
Since the etiology of pediatric hypertension is not fully known, a possible contributing 
factor to the current findings could be increased sympathetic nerve activity. In fact, emphasizing 
the likelihood of this interpretation is a number of adult studies demonstrating a positive 
relationship between BP and directly measured sympathetic activity (22; 94). As well, an analysis 
performed on the same participant sample (Fitzgibbon et al. unpublished) reported significantly 
elevated low frequencylhigh frequency heart rate variability ratio in the EBP group compared to 
the NBP group, indicating increased sympathetic outflow in the EBP cohort. Hence, a possible 
mechanism for the observed increase in systemic PWV could be an increased sympathetic 
outflow leading to peripheral vasoconstriction and reduced arterial diameter, causing an increase 
in overall BP (29) and increased peripheral PWV (69). In tum, since sympathetic activation has 
little influence on the more centrally located arteries (i.e. CCA), this explains the lack of change 
in CCA distensibility found in the current study. Overall, the lack of central arterial adaptations, 
but an increase in systemic arterial PWV in the EBP group suggests that increases in systemic 
arterial tone and BP precede significant central arterial adaptations. Therefore, these results shed 
some light on the mechanistic pathway that leads to pediatric hypertension. 
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5.3 Limitations and Future Considerations 
Although the current study adds new knowledge to the literature, there are recognizable 
limitations that need to be highlighted. Firstly, BP of the EBP group was low when compared to 
similar studies attempting to investigate the role elevated BP plays in arterial health. In fact, 
although significantly elevated in comparison to the NBP group, according to the 1996 National 
High Blood Pressure Education Program (23) (which measured BP in over 80,000 children within 
the United States) the BP of the EBP group was below the 90th percentile, technically designating 
them as normotensive. This difference could possibly explain the lack of correlation between BP 
and central arterial IMT and distensibility. 
Secondly, it would have been beneficial to measure PWV within specific segments of the 
vasculature. Measuring from the EeG to toe pulse consists of a very large vascular segment, 
while having several smaller portions would have allowed for a more detailed analysis of local 
arterial changes along the vascular tree. This in tum would have strengthened our findings 
allowing for a comparison of central vs. peripheral instead of central vs. systemic vasculature. 
As for future studies, it would be interesting to follow the same cohort of children over 
time and create a time course for if and when central arterial thickness and stiffness adapt to 
chronically elevated BP. Having a larger sample size with higher BP in the EBP group may 
satisfY some of the above limitations and considerations (see power analysis calculations in 
Appendix 7). Although lipid profiles were measured in the current study, they were not included 
in the analysis. Future consideration of lipid profiles might provide a clearer picture of the 
potential interaction of obesity, elevated BP and arterial characteristics. In addition, future work 
could incorporate baroreflex function measures to clarify the role the baroreceptors have in 
chronic BP elevation and how this relates to arterial structure and function. Furthermore, an 
exciting direction would be to investigate regional arterial changes to autonomic disturbances 
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such as elevated sympathetic activation in children with chronic disorders such as hypertension 
and obesity. 
5.4 Conclusions 
This study showed a significant increase in systemic PWV, but no difference in central arterial 
IMT or distensibility in children with elevated BP aged 11 to 14 years after controlling for age, 
PRY, sex and BMI. This study suggests that changes in systemic arterial stiffness precedes those 
more centrally, and may result from sympathetic predominance in children with above normal 
BP. 
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Appendix 1 
Research Ethics Board Approval 
PROM: 
TO: 
Linda Rose-Krasnor, Acting Chair 
Research Ethics Board (REB) 
Terrance Wade, Community Health Sciences 
Paul Leblanc, Deborah O'Leary 
",-,PI=L=E:.!.....: ___ 07-060 - WADE 
DATE: October 1, 2007 
The Brock University Research Ethics Board has reviewed the research proposal: 
Social Determinants of Child Hypertension 
The Research Ethics Board finds that your proposal requires clarification: The researcher 
may proceed with the work as soon as the following issue( s) have been addressed and 
received clearance by the Board: 
Section A - General Information 
5 - Other Ethics ApprovallPermission 
Please forward approval from the NCDSB once it has been obtained. 
*TI'his(litprbvtftl{wiitl/j~;"§okght8up6nre~eivl1JgJ)rockC:!niYetstty'l!;thics ·apj{f9v4t 
Section D - The Informed Consent Process 
Consent form 
Please explain the Tanner stage instrument and how it will be administered. Will 
parents be present? 
*ri<e X<!:nner 
as nthase 
BpnAge1N1c $ys'tem 
r~tfAbye{j. .1nU$ pZae(!, sk~l~tr:iZil'uJttlrity 
2znv4sdvepr?~ecl«reus~ngthe·Sunlight 
,TelAyiV,!s,rael»tpdetermine ske1(Jtalage; 
This,~rotocol hCfsprevi~,y:~ly 
*"fl?leaJe:seeatt(l.s,~1l'le'!tlfl;tt 
cqmpqsitiortpar?tgt4ph 
n' approved {n: 04,..419£0 Deborah 0 'Lea 
'Overviewof La Visit4:ndr~stingProcedures', ./,Jody 
18 - Consent by an authorized party 
Please clarify the verbal assent process and provide a script or guideline for 
obtaining verbal assent. 
*,*please, .. see,att?tcb'fnetit~ntttled.,;:'lil1e~f .. ·,l{erbaZ4;ssel1t .. G«tdetines.,'jor.a··deta'tiedoutline 
()fthetelephone·,scl;iptfofr.oqtainingV'fZ."hai·.assent. 
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**,4.s vyell, please see att(lchment entitled 'HBeat Ctmsent Form 'for the consentform 
that parents and chXldren will read and sign in the lab prior to testing that will again 
detail the lab tests lliid testing protocol. 
Please add a statement to all participant materials that advises parents to keep a 
copy for their own records. 
**pleasesee attachment entitled 'Information LetYer topqrents J, paragraph three. 
* *Aswell, we will provide them with a copy. of the ((ansent form at their lab visit. 
20 - Feedback to Participants 
In your application, you state that parents may access their individual child's 
results by contacting the researchers. This information should appear in the consent 
form. What explanation would accompany these results? Please make it clear to parents 
that results are not diagnostic. 
**please see attae7!ment entitled 'Information and Consent 'for/his information. 
For each point of clarification, please highlight the changes you have made on the 
corresponding documents. 
If you would like further information or assistance in responding to these clarification 
requests, please contact Lori Walker (ext. 4876) in the Research Services Office. 
No research with Human Participants will commence prior to receiving ethics 
clearance from this board. 
LRKlbb 
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Appendix 2 
Parental Take-home letter 
Dr. relIance ,'l!arle " eIIt 414.6 • twade@llrodl:u.£:il 
Dr; ~b!lrah Q'LlIilry • tl'14 J3S ., mlllilry'li'mvr;Ku,C\! 
tlr; Paull.eBJaflC ., at 42Hl • pleblmc@brcdtu.ca 
I!l!Cwlltly yoo were cont.actl.ld by HBillat (H@art Bmallll)urai Environmental ASiSll~rnel1t Tllam) regarding your child being rarniomly ch1:t>en to 
paftklpate In the seam!! p has:e attire research ,tudy to l!xamll1e hlghlJlooc pressure (hypertemiOO).lhan k you for vniunteerln!) to p:artlClpate In till! 
second phasll oftlw studiyl As we dlsru~s@d, ytlu :lnd your mUd IIk>!ly ~!Nl:Ody COi'l1j)~ted $(.ome qW!stlonl'lalll!s that wllfe 5l!nt home from smoo!fof 
tlw first ptuls:e ofthe stll1:fy: Atl:choat your child dlso had tMir blood pr@£SUf>f!, hl1lght Mfght, hlp and W;;Jlst clrcurnlllrerlOlHmasuroo am! comp!etOO 
50me questtoonalres about their pnyslcal activity. 
For th!!; phase 01 the st!.i'd~ the te:itln!l will take pla:w at BrQ~k IJnlvefSlty.1'he total testing si1wldtake abQut 11k hours. We aSK fuat'lhe "afent! 
guard.lan Is pmsentfnT .at I!<astttll'!flrst half·hollt Yl:lur cnlld III1H rru:I!IV@$20asa toi:@n of our apprnd<lt1Ofl fmyou and your mild's partlclpatlilli II! 
thl. pha se of tM study. 
Althoug h we already dl501ssed wme oHhl5 InfmmaUoo over the poone, we· aSK that YlJI.l reoo the attached informatlOflfOfm detailing tile visit dml 
testing procelfures tllat wHi iMl done (Overview of Lab Vlsft. and Testing i"roci'duf1!sj. ami mp the information for yOO! records. 
Some factors 51.1 eA as rood, e xercl>e and ie mperature, mayaffe d th" lab Wits. Therefore, W'.l a~k that ¥Qur 'Aila tfu,es not eilt o[ drink al1:rti1lng exC(!'pt 
\Y<!ter once they DO to bed tM nl!lil'l befon~ testing. WI! will provide your eNid wlth analler\1Y.sensltlve meal tllat morning, WI!! also .<lsk tIla! )'OU! 
mild avoids caffeine (for example,. caffe, tea., cola) alia refrains from eXEf(lsethe morning oftestlllll. Flfla!!y, your rolld should either ile dressed In 
atliietk atttre (shorts, t-shlrt; Of tank top aoo running shoos) or bring th!!5!l doilies to the testing ~s51O!1, 
AUrt~ b~~nn!rl'f! 01 your visit to Brodt Ur;f1M~Ity; we wll! g() over the j:ob Ilrocedulrr.:and yem wlll hdllean 0!lPMunlly to ask <lny ql.ll!stkll1s relatlld 
totOOt>f!sts. Ollceyollarl! sali>flerl, we wi II have yOlii and your child sign a oonsootlWrn to.aUowyom child to jlQrtk:lpate In this phas~ crftlle HB~at 
ffisean::h study, 
this study haslJeen fwlewoo and appf~ by tlte Research Eth KS ellard, from both Broct University ami the Niagara Catho!tc DIstrict smool 
Bo.arc.lf you haw. ~ny <iUmon$ about 'the study or lab te,tlrt!l proct!!lUI'!!S, please contact or. Ol1!bwah O'l>f!ary at 905·638·5550 (x4339), Dr. Paul 
leBlanr at S05·6Slfl·5550 (X4216), or Dr. Tllfram:~ Wadi! at 905·6Slfl·5S5D (x4146). If yoo havl!any furthw q!.le5tlolls r~rdln\l your rights a, .<1 
r~sean;h parttcfpant, contact the Re$eardl Elhltli Officer in the Qfflce of Reseann SerViCES at {90S) 688-5550 {;(H13S} or email at reil@lhnx:ktLca. 
We are wry grateful that yoo and yoor dJ ikl hav~ agreed to tilke part In this IfI1jJOrtant study. lhank yoofor your time. 
Paul LeBlanc. Ph.D. 
1 PrlndpallllVl!stlgators: Dr. ~NlInCe 1. wade • Of, [)~h O'Leary- Dr. John t:almEY 
(o·investlgaIOls; Dr./'aulll!Blanr.0 Dr. Jan Llu. Dr. Colle,m Hood- Dr. Jolm Hay • Dr. Paooglota KI."trou • Dr, Brian Roy • Dr. Dawn ZInga. I)r. Kwln Shoemaker 
2 I'll" 06-31 5 WADE: R~serch SemceJs • 8.we!< Un!wrsJ\v. Room ellS. 9(15.689.555Q eJ<\:4315 
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.Appendix 3 
Parental Information and Informed Consent Forms 
SOCIAL DETERMINANTS OF CHI LD HYPERTENSION 
Your cl1 lid Is Invlb!d to p:lrtlc~ III a mllilrch rillIdy bilng 00IIdi..Kmd by the 
Irlltstlgakn IIstid bllle.,. Friofw paltlclpatlng In th15 ~' !pu au .sud to l'Qad :mil slgn this fi:lm, Mh:h out! m tiKl purpoSt anj glvmo a I'iQiaUIid 
dw..alptlm of tile tmlng procedures used In thl!: study. 1Iu! mtlng promdures will be! «Inducted at Brock Ur,MlFstty; 
PrimarylnvI)stigatols D~par1ml:!nt Jlhon~ email 
DL l)!!Ilooo O'taay 
Dl Paull.eBliIiIlc 
PURPOSE 
Cnmmulllly H!!:!lth 'kII!llCl!§ 
COI1ll1lUil!tY H!2IthSdi!llCl!5 
Community Hilalth Sdences 
(005) 6811-5550 Y414fi 
(!IOSl 6Ba·.555(l X4339 
(905) 68&-5550 ).<1216 
dcleartotfodlJ.ca 
pleblanc@broaru.GI 
Adutb h Canada :me 11'11\ Unltr!d stm!5 hM J 00% IIff!tlm~ !15k Of Ce\lQloJl'fIIg hl;1 blood pn!'lwm, ::ISO mllW!1 lIS h:nmrtMslon. HI;1 blood 
pre5Sl.lJf (liSp! is one mille str~est predk:tllls of heat disease. Some mmtlst5 liI9!iest that HBI' mil}' start 111 childhood, !rut we 00 nat know 
what factor> m:IY b!I InvolllilC. This Wdy '11111 mil) tIS loam whilt m::tms m:ly cootrloot@ to ml klhood hypr.ellSloo. If \1m can loam whatthQiQ 
fa!:t!l!'i "fil, Wi'! mgbt be abie to Qfhr sugges1!Of15 to tamll!e5. st:!loo15. and (OmmU1I11I6 to lrnprwe Ute lleill't l1ea!1h of dlldrel'l.l1!ls !cnowloogl! 
aluld he,lp all t;hlklren ill CCIl'lW lead healthier l!ve~ ami redUC!! fuelr mance of hIMng neart d!3!!U! as adults. 
OVER11lEW OF LAB VISIT 
Upon 0111'11131 at BRId 1J1I1\'tl1S11\t you ,,00 your child wi!! bt famIliarized '.vftI1 ttle IaboratotY al1d the te.1lnllllfOceWfe'S VIlli be exrAalnl!(l. <lna! 
yeu ale wtlsfled wIIh fue 9planation oj' the testlng pw..edures, you and your dll kj willther! be asked to leild the Information snee1 about the 
study :lnd s!gn lhlf «IlISmt form. If your cilild Is not:lll'Q:ldy WIlal1ng :rtI111l1l( attIfIl, mgillll will 1m asktd to cha~ lnihll! \\!3iIlOOfll. 
The testing Mil begin with tile chId's blood test min!! a finger prick to obtain f.wll: or ihlee drflpll of blolld fur analysis. FolklWin!;llhls, YG'1lI' mild 
will m. glWII <In allwgy >I!I'l§1ti!.!@ 1Ir".a!d;l§t 1KOO't! anyfurtl'lAl' tfitlng. 
A1m !hey hJw filli!!heti bre~t, tIlcy will a£o be asked to empty tRJlr bl:idder, as this t~~ belln shawn to Ime 311 efftitt 00 bloml prcswro. 
Stfilre' tl!stll1g b1000 pressure. YOUI' child VII. Ill! III a slWng Ilcsltlcn fer 15 mlntru!S. l11a tum bloOO pressure Will be taten USinlJ an alltommr 
oDed plessure mooltar (the DIU unit tlm; was previously usetill1 school tc measule yoor thld's blood prmure). 
Ntxt. your dnid's 'Mllgllt. height. sklnf~ ItIlckllesS. 'li!/aiot crcul'llference. hlp <lraJmference. and skEletal f1'IdtIJrItY WI If be rerordl!d. Flnall!g tile 
d1l1d wlll lie down ami have herlhls heart r* mOl'llblred and have ihell heart I11'III rgln: carotid altery {artery in the ned:) 1maeed UQllg Doppler 
uU:rasam1l ~ same Wi)!! of ultrasound sem In a hDspltal}.At h mlloftestln~.yoor mild Will rl!Cl!wl! SZII as a woon of 001 appm:la1lmlnr 
yrur liWOlvement In the i1udy. 
i':!f!!nts are mllfl! ti10m weialm& to !le Ilresentfor !esthg. 
Brock U11iversity' ST. C Pi T II II It I H es • 0 N T A It I 0 C A tel Pi I) A • W 'II W • B It 0 C I{ II . r. ,I\. 
Brock U11iversity 5 T. CAT II II It I !4 e 5 • 0 N 1 A It i 0 c: A. N A 0 II • W W W • 6 ROC I( II < C A 
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OVERVIEW Of TESTING PROCEDURES 
The fnliowlng proctlMS am described In further detail below: 
Blood Analysis 
Blood Pressum Measurement 
Body Composltloo 
Heart Rate 
carotid Artery and Heart Ultrasound 
TESTlfHi PROCEDURES 
Blood Analysis 
OVERVIEW OF LAB VISIT AND TESTING PROCEDURES 
FInger pinprick blood sampling ·The middle finger of the noo-domlnant hand (@.g. If right handed. the mkldlellnger of th@ left hand will be 1JS@d) 
Will be prldced so two drops of blood QII be sampled. They Will feel the small prick but will not feel any pain or discomfort for the r@malnder of 
the sampling. the tip of that fingllf may feel sensftlve and a little bit sore for about a ~ It Is Important to km!p the site clean and covered WIth 
an adhesive bandage I.II!tn It is healed {up to 24 hours) to minimize any risk of Infection. 
Blood Pressure 
Blood pmslJl'll Is monitored using a non-invasive method. The method illVl)M!!; an automated arm cuff system that Is similar to the method lJ5ed 
In a doctor's office. A cuff Is wrapped aroond the UflPer arm and is Inflated fuen defiattHI.AfW s,lttlng Ina mstlng posltloo fur 15 minutes, full' 
child will have thlllr blood pressure taken automatically. 6 tlmes In 1 minute InteNals. No rlsk Is Involved. 
Body Composition 
All body composltloo measures Will mile plm behind a portable curtain for privacy With the parent prt!sent If desired. Height, weight, hlp and 
waist dltllmrence WID be measured. Sklnfold thickness WIll 00 assessed using a non-Invasive method that measures skin thldmess.lhe testI!f 
pinches the skin at the appropriate site to false a double layer of skin and the underlyin!l adipose tissue. but not the musde. ibe calipers are 
then applied at right angles to the plm.n and iii reading Is taken. SIClnfllld measures WIll be taken at two sites including the subscapular (lower 
shoulder blade} and triceps (back of the upper arm}. No I1sk: Is Inwlved. Next, yoor diUd's forearm. lower leg and wrist Will be measumd using 
Doppler ultrasound to gauge skeletal matu~ thl!' ultrasound techniqul!' used Is completely non-Invasive and similar to that used to Visualize the 
development of a baby during pregnancy. Again, 00 I1sk: Is In~. 
Heart Rate 
Heart rate will be measured using sensors plamd 00 the skin of your dilld's upper chest. these mnsors are @Iectrodesused to detect the eli!ctrlcal 
actiVIty generated by the heart and do oot transmit electrlcal signals Into the body from the heart rate monitor. No risk Is Iilvolved. 
carotid Artery and Heart Ultrasound 
All carotfd artery and heart ultrasound measlJl'lls WIll be tallen In a lying posltlon In a prIVate< room. In addltloo to the u Itrasoond previously men-
tloned, two morn ultrasound measures wiD be performed. FIrst, the carotldaftllry ultrasound Will be pl!l'fOl'lll@d IJ5lng a smalltransdUCllf to \IIsual· 
lze the carotid artery. As well, carotid wry blood pmssure will be Simultaneously obtained using alhln pen-like deVice that Is hgbtly pressed 
against the neck. Both the probe and pen 1Ikl!-rlevlce wll! be pmsmd against the neck on OPIli'lS1t!! stdes. It Is a non-Invasive procedure. Serond, 
the ultrasoond of the heart will be performed WIth a small probe placed ll!!tWeen your child's rlbs on the left side of thelr dim. This procedure Is 
also noo-invasllle and 00 risk Is IlIVl)ived. 
Brock University s T. CAT II A R I N ES • 0 N 1 A RIO CAN A D A • WWW.B ROC K U • C Pi 
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OVERVlEW OF tAll VtSIT AND TESTl~H'i PROCEDURES 
POTENTIAL RISKS AND DISCOMfORTS 
PleasE refef to the "Testing Procedure5" prevllJusiy mentioned fur a complete de,{:rtptloo of the procedurE> tow performed during the study 
and the pot£ntJal r15K, associated with these procedures. 1f M! InjUl)' OCCUT5 at any time during the InvESllfjatlon, JPllrilllrlate !lrst afd/CPR will be 
aominl'ltlirild ~nd 1'00 will D!!<ldvls..dto 'Ilal: I1OCQSS.ry m9'!ljGI help. 
BENEflH AND REMUNERATION 
A potlllljJ;:I1I:mnefitlor your chUd's particlpJtklnll1lhls prolect Is th~ knQWt~dgt1 oftheJl blood pressure, illlart JOOJITcry ;;\,5CS!'imCrr~ J$ well 
as allY urnderlylng cardIovascular dfsease risk factors. Your rn Url will aiso be reimbursed $20 as a token ()f ollr appreciation for YOlllyour chfld's 
Involvement In the study. 
All data collected ourlng this stu~y will remain cmlTidentlal and stored in offices and on SlKured computers to which only the prlnclpalllWeJi' 
tlgatof5, co IlJ!lcstfgators, project coordinator, Jnd rcs!!Jn:h aS51stJm5 will have ;JCCCS5. The {!Iectronic nle contalnlrr~ j'IlUF JI1,Wer5 Jnd body 
measurements wJ1l ;)nly contain III !.ml'll.le ioet]t1ficaUlJn numoor and no other ldentlfyln~ Infulmatkm to Bnsure your 111foDnation Is completely 
anonymous. You shwld be al,vare tnal the results of this study will be maaeJValiable tn the SCientific (oll1ll1l1nli)!, through :publlcatll1n In SCientific 
Journal.; ho\Wvw, we wm only u.~ the combl ft!!d cl~u from familJQs &0 ih~ 1'10 1.>111919 m Ikl Of larnlly can 011 fdgnUfuld. You wllllwJ{! ac{{!,s ro 
your mIld's data, as well as the group data vl'hilnlt Decomes available and If y01J are inlerest{lr\. Please cootact the researchers directly if you 
wtsh to 0 Iltaln this Intmmatlofl. 
PAIlTl~IPAnCUt AND WITHDRAWAL 
Yo u (an cnoose vmether your ch lId partlrlpate. In thJs study Of nat. You may exerdsa the option of femav Ing your child's datafrnm the silldy II 
ytr1J wish. You may a!5!) r>:lfiJS~ t!;) amww any qU9>tlons pos~cl to you and/or yom {hllil during thll study <llld stili n;mull'I as a p;artk1llant In Ihll 
study. The lnvestlgators reserve the right to wnndraw your child from the Yudy If ttmy believe that circumstances have arisen \Ylilcn warrant 
doing so. 
RIGHTS OF RESEAR~H PAIUICIPANTS 
You may wttMrd\\1yr:mr Ci)n~l1tto partkljlate m thrs study at any tlme, amJ yoo may also d15Clll1tlnue the particlpatlon of yOUf child at any time 
WtlrnH.lt PQl'laity.ln signing this {oI'l5@ntform>Or1'11 partlcfp:rtlng In this study you ar:g I'lot MlVlng ,;my klgal claims or TIlmi!l.i11M. This sillOj' has 
beet] reviewed amJ recelved clearal1t:€ from the Brock University Researm 'Ethlrs Board (FIle 07-000 -WADEj.lf YOll have any furth·er questklt1s 
regartlll1~ yoor rigl1ts as a reSBarch participant (()fltacttl1e Research Ethics OOlcer In th~ Olllceof Research Servlce, at {90S) 68a.555iJ x3Q35 or 
email at f~b@brm_(a. 
INFORMATION 
Plg<lSiHx>I1t.rt Or. L'Iflboran O'iIA!:lf)' at 905-6&8-5.550 jk433 9), Dr. P;iul !..l!IliJnc at 905-6!la-S550 jk4216j Of Dr. T~lrantll wadl!,ill 905-683·5550 
(x4146} If)'Ou have any qllestlo ns aOOut the study. 
Brock University ST. CAT 1'1 A R I N t 5 • {) N TAR! 0 CA til A D A • W WIN. B ROC K U . C A 
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H'HORMED CONSENT 
I have read and understand fne aimve explanation of the purpose and procedures of tile projed and I am aware of 
the potentia! fish and my rights as il research participant. I !.lIlderstand that I can gain act.ess to my child's individual 
results by contacting the resean::ilers, and I understand that these resulfs are not a clinical: diagnosis. MyquestioflS 
have been answered to my satisfadion and I agree to allow my mild to p.artidpate in this study. 
[ONSENT FORM 
i:J t aa give pamlssion for my cbild tn participate ill the 8rOO. University HB€at Jab cmnpo!1ern mnoocted by. Dr. Terrance ]. Wadl'; DtDe!Joran O'l1!alJ' ami 
Dr; 1'ilull1!Blafic 
i:J ! ria nat give pErmtssioo fO! my {hild ill participate In the IlI!1d; University Imeat lab componeflt conducted by Or. Terrance 1 Wadl'; Dr. Df!oO!an !J'l1!afyand 
DL 1'ilul tellillDL 
Signature of ParentfGuardian: Date: 
Signature of Student Date: 
Printed Name of Student 
In addition to the current study, data collected may be u~ed later to answer other researdi questions that may arise fram this study. We 
would I1ke your permission to keep file inlormationthat you aooyour child provil'redon file after this research study is over;AI! stored 
personal datawi!l be kept strictiy confidential aooail information wi!! be coded so that no one wi!! be able to identify ~fOU or YOOf child. 
At any time, ynu can ask to have your Information removed and not included In any future projects by contacting Dr. Terrance 1. Wade 
!9G5-6llB-5S511 ext 4146) Of Dr. Deborah Oleary.(905-68g,5550 ext 4339;. 
i:J ,do gi~e pamlss1QIl to have my information and my child', inlonnation ,tored in use to answer future researchqu!!5tions after the HBea! study is over; 
Signature 01 ParentfGuardtan: Date; 
INVESHGAIOR 
In my Judgment the participant [5 vo!untarily andknowlngrl gilltnginfurmed coosent and IIDss!'!5&es the lega! capacity to give Informed mnsent 
and part.idpate in this research study. 
Signature of Investigator: Date.: 
BrockUniversity S 1. ( II T 11 II llllH 5 • () IH II !11 (j (II N 1\ D A • IN W W . Il !I (} (l( U , ( II 
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Appendix 4 
Participant Information 
LABORATORY INFORMATION SHEET 
Date: 
---------------------------
Time (am/pm): _____ _ 
Student ID#: 
Gender: 
Allergies: 
Medical Concerns: 
Height: 
_____ cm 
Name: 
DOB(mmddyyyy): 
Medications: 
Sitting Height: ______ (-74) = Weight: 
___ cm 
____ kg 
Age: 
BMI: 
(kg/m2) 
SECTION 2: QUESTIONNAIRES and CONSENTS 
STUDENT PARENT 
1. Consent (signed): Y N 1. Consent (signed): Y N 
2. Current Med History: Y N 2. Missing Data (PQ & CQ), Sleep Questionnaire: Y 
62 
N 
______ cm 
Examiner: 
SITE TRIAL 1 (mm) 
SUBSCAPULAR 
TRICEPS 
SUM OF SKIN FOLDS: _____ (mm) 
1. Have you had your period?: Y 
3. How often do you get periods?: 
___________ days 
Examiner: 
N 
... , 
TRIAL 2 (mm) TRIAL 3 (>lmm) MEDIAN (mm) 
PERCENT BODY FAT: ____ (%) 
2. How old were you when you first had your period?: 
_____ yrs 
4. How long does your period last for?: 
__________ days 
Frequency: 10.0 mHz Power: 0 dB Persistence: tum to minimum 
Depth: cm FPS: change focus # (decrease to 2) to increase fps 
Pre 1 Post 1 
2 2 
3 3 
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Systolic Diameter: mm Compliance: 
Diastolic Diameter: mm Distensibility: 
Diameter Change: mm CaPP: mmHg 
Baroreflex Sensitivity: ms/mmHg MeanHR: bpm 
SECTION 7: LEFT VENTRICULAR MASS MEASUREMENTS 
Examiner: 
Probe: _____ _ Depth: ______ em 
B-Mode Images: M-Mode Images: 
Interventricular Septum (end-distole): em Ejection Fraction: % 
Left Ventricular Diameter (end-diastole): em Circumferential Fiber Shortening: 0/0 
Left Posterior Wall (end-diastole): em Stroke Volume: mI 
End Diastole Volume: mI Left Ventricular Mass: g 
End Systole Volume: mI Left Ventricle Mass Indexed by BSA: g/m2 
Left Ventricle Mass Indexed by HT: 
64 
.... 
Appendix 5 
Years from Peak Height Velocity Equations 
Boys: Maturity Offset = -9.236 + 0.0002708·Leg Length and Sitting Height interaction 
-0.001663·Age and Leg Length interaction +0.007216·Age and Sitting Height interaction 
+0.02292·Weight by Height ratio, where R = 0.94, R2 = 0.891, and SEE = 0.592. 
Girls: Maturity Offset = -9.376 + 0.0001882·Leg Length and Sitting Height interaction 
_ 0.0022·Age and Leg Length interaction +0.005841·Age and Sitting Height interaction -
0.002658·Age and Weight interaction +0.07693·Weight by Height ratio, where R=0.94, 
R?=0.890,and SEE = 0.569. 
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Appendix 6 
Statistical Output 
Descriptives ofNBP (0) and HBP (1) children 
hyper N 
trueage 0 85 
1 21 
phv 0 85 
1 21 
student gender (M/F) 0 85 
1 21 
(em) 0 85 
1 21 
Mean of Weight Measures 0 85 
1 21 
Body Mass Index 0 85 
1 21 
LabFieldAveS 0 85 
1 21 
LabFieldAveD 0 85 
1 21 
LabFieidMAP 0 85 
1 21 
hyper N 
sdave 0 83 
1 21 
ddave 0 83 
1 21 
diamdiff 0 83 
1 21 
DistwFINApresPP 0 83 
1 21 
FinapresAdjPP 0 83 
1 21 
pwv 0 56 
1 15 
imt 0 83 
1 21 
Mean Std. Deviation Std. Error Mean 
12.7637 .81889 .08882 
13.0564 .91345 .19933 
-1.7080 .80756 .08759 
-1.6800 1.04358 .22773 
.3412 .47692 .05173 
.4762 .51177 .11168 
157.9812 9.28567 1.00717 
160.5524 9.42595 2.05691 
46.7094 11.56612 1.25452 
65.0659 19.58840 4.27454 
19.3963 3.59042 .38944 
25.9490 6.47583 1.41314 
90.7725 5.00845 .54324 
110.1429 6.11198 1.33374 
55.1431 4.77857 .51831 
70.8810 5.38443 1.17498 
67.0196 4.38267 .47537 
83.9683 4.84973 1.05830 
Mean Std. Deviation Std. Error Mean 
5.4319 .43048 .04725 
5.6011 .38638 .08431 
4.8256 .43039 .04724 
4.9434 .39280 .08572 
.6063 .10947 .01202 
.6124 .10959 .02392 
.006397623 .0018895849 .0002074089 
.005820455 .0024317884 .0005306597 
44.2750 10.76881 1.18203 
51.7680 12.49781 2.72725 
389.4854 24.20355 3.23434 
423.1360 35.07687 9.05681 
.4192 .05744 .00631 
.4304 .05085 .01110 
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Independent T-test for children between NBP (0) and HBP (1) 
Levene's 
Test for 
Equality of 
Variances t-test for Equality of Means 
95% 
Std. 
Confidence 
Interval of the 
Error Difference 
Sig. (2- Mean Differe 
F Sig. t df tailed) Difference nce Lower Upper 
trueage Equal variances 
.694 .407 -1.433 104 .155 -.29262 .20419 -.69753 .11229 
assumed 
Equal variances not 
-1.341 28.46 .191 -.29262 .21823 -.73931 .15407 
assumed 3 
phv Equal variances 3.291 .073 -.134 104 .894 -.02797 .20909 -.44259 .38666 
assumed 
Equal variances not 
-.115 26.21 .910 -.02797 .24399 -.52930 .47336 
assumed 9 
student Equal variances 2.196 .141 -1.145 104 .255 -.13501 .11790 -.36881 .09879 gender (M/F) assumed 
Equal variances not 
-1.097 29.18 .282 -.13501 .12308 -.38666 .11663 
assumed 3 
(cm) Equal variances 
.150 .700 -1.133 104 .260 -2.57120 2.2694 - 1.9291 
assumed 2 7.07155 4 
Equal variances not 
-1.123 30.32 .270 -2.57120 2.2902 - 2.104C 
assumed 5 6 7.24643 3 
Mean of Equal variances 3.2860 - -Weight assumed 6.696 .011 -5.586 104 .000 -18.35646 7 24.8728 11.840 Measures 6 06 
Equal variances not 23.55 4.4548 - -
assumed -4.121 2 .000 -18.35646 3 27.5600 9.1528 4 8 
Body Mass Equal variances 17.98 1.0474 --Index assumed 3 .000 -6.256 104 .000 -6.55272 8 8.62991 4.4755 2 
Equal variances not 23.12 1.4658 -
assumed -4.470 .000 -6.55272 - 3.5213 1 2 9.58412 2 
LabFieldAve Equal variances 1.2766 - -S assumed .613 .435 - 104 .000 -19.37031 21.9018 16.838 15.173 2 9 72 
Equal variances not 
- 27.00 1.4401 - -
assumed 13.450 9 .000 -19.37031 3 22.3251 16.415 7 45 
LabFieldAve Equal variances 1.1942 - -D assumed .053 .819 - 104 .000 -15.73782 18.1061 13.369 13.178 9 4 49 
Equal variances not 
- 28.28 1.2842 - -assumed 12.255 6 .000 -15.73782 2 18.3672 13.108 2 41 
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LabFieldMA Equal variances 1.0908 - -- 14.785 P assumed .004 .949 104 .000 -16.94865 1 19.1117 15.538 7 52 
Equal variances not 1.1601 - -- 28.60 
-16.94865 19.3228 14.574 assumed .000 6 14.609 7 5 44 
Levene's 
Test for 
Equality 
of 
Variances t-test for Equality of Means 
Sig. Std. 
95% Confidence 
Interval of the (2- Mean Error Difference 
tailed Differenc Differen 
F Sig. t df ) e ce Lower Upper 
sdave Equal variances 
.564 .454 -1.641 102 .104 -.16918 .10313 -.37374 .03537 
assumed 
Equal variances 
-1.750 33.724 .089 -.16918 .09665 -.36566 .02730 
not assumed 
ddave Equal variances 
.372 .543 -1.139 102 .257 -.11780 .10339 -.32288 .08728 
assumed 
Equal variances 
-1.204 33.247 .237 -.11780 .09787 -.31687 .08127 
not assumed 
diamdiff Equal variances 
.002 .965 -.229 102 .819 -.00613 .02675 -.05918 .04692 
assumed 
Equal variances 
-.229 30.893 .820 -.00613 .02676 -.06073 .04846 
not assumed 
DistwFINApresPP Equal variances 
.000490 - .001549 1.39 
.242 .000577 .000395 assumed .241 1.177 102 1682 3635 8018 2 4653 
Equal variances 
.000569 - .001747 
.320 .000577 .000593 not assumed 1.013 26.427 1682 7527 3917 0552 
FinapresAdjPP Equal variances -
-2.71847 12.8850 assumed .621 .432 -2.756 102 .007 -7.49294 2.10086 2 
Equal variances -
-13.5818 not assumed -2.521 27.979 .018 -7.49294 2.97238 1.40408 0 
Equal variances -
- -
pwv 2.31 69 .000 33.6506 7.78263 49.1765 18.1246 assumed .133 -4.324 5 1 3 8 
Equal variances - - -
not assumed -3.499 17.725 .003 33.6506 9.61700 53.8776 13.4235 
1 5 6 
imt Equal variances 
.113 .738 -.820 102 .414 -.01126 .01373 -.03849 .01598 
assumed 
Equal variances 
-.882 34.134 .384 -.01126 .01276 -.03719 .01468 
not assumed 
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Correlations - Entire Cohort 
BP 
SBP DBP FingerPP gender Group (kg) bmi age phv Dist imt pwv 
LabFieldAve Pearson 1.000 .843" .297 
.. 
.142 .830** .67§ .660: .199 .108 -.034 .089 .589 ** S Correlation 
Sig. (2-
.000 .002 .151 .000 .000 .000 .043 .273 .733 .371 .000 tailed) 
N 104 104 104 104 104 104 104 104 104 104 104 71 
LabFieldAve Pearson 
.843 ** 1.00 .231 * .053 .791'* .49Q .504" .078 .021 -.090 .006 ** D Correlation 0 .419 
Sig. (2-
.000 .019 .592 .000 .000 .000 .429 .831 .366 .956 .000 tailed) 
N 104 104 104 104 104 104 104 104 104 104 104 71 
FinapresAdj Pearson 
.297 ** .231 * 1.000 .234 * .263** .362 .276: .169 .173 -.552 ** .032 .307 ** PP Correlation 
Sig. (2-
.002 .019 .017 .007 .000 .005 .087 .079 .000 .747 .009 tailed) 
N 104 104 104 104 104 104 104 104 104 104 104 71 
student Pearson 
.142 .053 .234 * 1.000 .116 .161 .061 .236 .156 -.119 .007 .273 * gender Correlation 
(M/F) Sig. (2-
tailed) .151 .592 .017 .242 .103 .537 .016 .115 .230 .948 .021 
N 104 104 104 104 104 104 104 104 104 104 104 71 
hyper Pearson 
.830" .791' .263 ** .116 1.000 .475 .518: .137 .009 -.116 .081 .462 ** Correlation 
Sig. (2-
.000 .000 .007 .242 .000 .000 .166 .927 .242 .414 .000 tailed) 
N 104 104 104 104 104 104 104 104 104 104 104 71 
(kg) Pearson 
.678" .490" .362 ** .161 .475** 1.00 .933" .293 .216 -.077 .099 .557 ** Correlation 0 
Sig. (2-
.000 .000 .000 .103 .000 .000 .003 .028 .435 .316 .000 tailed) 
N 104 104 104 104 104 104 104 104 104 104 104 71 
bmi Pearson 
.660** .504" 
.. 
.061 . 518** ,93~ 1.00 .101 - -.013 .109 .523 
.. 
Correlation .276 0 .054 
Sig. (2-
.000 .000 .005 .537 .000 .000 .307 .583 .894 .269 .000 tailed) 
N 104 104 104 104 104 104 104 104 104 104 104 71 
trueage Pearson 
.199 * .078 .169 .236 * .137 .293 .101 1.00 .743 -.155 -.120 .103 Correlation 0 
Sig. (2-
.043 .429 .087 .016 .166 .003 .307 .000 .116 .223 .392 tailed) 
N 104 104 104 104 104 104 104 104 104 104 104 71 
phv Pearson 
.108 .021 .173 .156 .009 .216 -.054 .743 1.00 -.131 -.093 .058 * Correlation 0 
Sig. (2-
.273 .831 .079 .115 .927 .028 .583 .000 .185 .346 .632 tailed) 
N 104 104 104 104 104 104 104 104 104 104 104 71 
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DistwFINApr Pearson 
-.034 
esPP Correlation 
Sig. (2-
.733 tailed) 
N 104 
imt Pearson 
.089 Correlation 
Sig. (2-
.371 tailed) 
N 104 
pwv Pearson 
.589" Correlation 
Sig. (2-
.000 tailed) 
N 71 
.. 
**. Correlation IS significant at 
the 0.01 level (2-tailed). 
*. Correlation is significant at 
the 0.05 level (2-tailed). 
-
.. 
.090 -.552 
.366 .000 
104 104 
.006 .032 
.956 .747 
104 104 
.419' 
.307 
.. 
.000 .009 
71 71 
Regression Analysis - Pulse Wave Velocity 
Variables EnteredIRemovedb 
Variables 
-.119 
.230 
104 
.007 
.948 
104 
, 
.273 
.021 
71 
Model Variables Entered Removed Method 
I true age, bIni, 
student gender . Enter 
(M/F), hyper, phva 
a. All requested varIables entered. 
b. Dependent Variable: pwv 
Model Summaryb 
-
-.116 
.077 
.242 .435 
104 104 
.081 .099 
.414 .316 
104 104 
.462" .557 
.000 .000 
71 71 
Std. Error ofthe 
Model R R Square Adjusted R Square Estimate 
1 .623a .388 .341 24.22978 
a. PredIctors: (Constant), trueage, bml, student gender (M/F), hyper, phv 
b. Dependent Variable: pwv 
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- -
-.013 
.155 .131 1.000 .126 -.188 
.894 .116 .185 .204 .116 
104 104 104 104 104 71 
.109 - - .126 1.00 -.011 
.120 .093 0 
.269 .223 .346 .204 .930 
104 104 104 104 104 71 
.523' 
.103 .058 -.188 -.011 1.000 
.000 .392 .632 .116 .930 
71 71 71 71 71 71 
.. -. 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 24523.187 5 4904.637 8.354 .000' 
Residual 38747.438 66 587.082 
Total 63270.625 71 
a. Predictors: (Constant), trueage, brm, student gender (M/F), hyper, phv 
b. Dependent Variable: pwv 
Coefficientsa 
Standardized 
Unstandardized Coefficients Coefficients 
Model B Std. Error Beta t Sig. 
1 (Constant) 409.502 90.520 4.524 .001 
hyper 20.959 8.177 .287 2.563 .01: 
student gender (M/F) 13.487 6.172 .214 2.185 .03: 
bmi 2.042 .600 .381 3.404 .00 
phv 6.744 6.304 .186 1.070 .28' 
trueage -4.240 6.440 -.114 -.658 .51: 
a. Dependent Variable: pwv 
Residuals Statisticsa 
Minimum Maximum Mean Std. Deviation N 
Predicted Value 371.2146 467.2689 396.3051 18.58486 72 
Residual -56.72359 61.77820 .00000 23.36105 72 
Std. Predicted Value -1.350 3.818 .000 1.000 72 
Std. Residual -2.341 2.550 .000 .964 72 
a. Dependent Vanable: pwv 
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Reliability Analysis 
- Intima-media thiclmess measures 
Intraclass Correlation Coefficient 
95% Confidence Interval F Test with True Value 0 
Intraclass Correlation8 Lower Bound Upper Bound Value df1 df2 Sig 
Single Measures .577b .394 .764 9.191 19 95 .000 
Average Measures .891 c .796 .951 9.191 19 95 .000 
Two-way mixed effects model where people effects are random and measures effects are fixed. 
a. Type C intraclass correlation coefficients using a consistency definition-the between-measure variance is 
excluded from the denominator variance. 
b. The estimator is the same, whether the interaction effect is present or not. 
c. This estimate is computed assuming the interaction effect is absent, because it is not estimable 
otherwise. 
-Diastolic diameter measures 
Intraclass Correlation Coefficient 
95% Confidence Interval F Test with True Value 0 
Intraclass Correlation8 Lower Bound Upper Bound Value df1 df2 Sig 
Single Measures .913b .794 .965 22.020 19 19 .000 
Average Measures .955c .885 .982 22.020 19 19 .000 
Two-way mixed effects model where people effects are random and measures effects are fixed. 
a. Type C intraclass correlation coefficients using a consistency definition-the between-measure variance is 
excluded from the denominator variance. 
b. The estimator is the same, whether the interaction effect is present or not. 
c. This estimate is computed assuming the interaction effect is absent, because it is not estimable 
otherwise. 
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-Systolic diameter measures 
Intraclass Correlation Coefficient 
95% Confidence Interval F Test with True Value 0 
Intraclass Correlationa Lower Bound Upper Bound Value df1 df2 Sig 
Single Measures .976b .939 .990 80.931 19 19 .000 
Average Measures .988c .969 .995 80.931 19 19 .000 
Two-way mixed effects model where people effects are random and measures effects are fixed. 
a. Type C intraclass correlation coefficients using a consistency definition-the between-measure variance is 
excluded from the denominator variance. 
b. The estimator is the same, whether the interaction effect is present or not. 
c. This estimate is computed assuming the interaction effect is absent, because it is not estimable 
otherwise. 
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Appendix 7 
Post-hoc power analysis 
The following sample size figures have been selected to proved valid inferences of required 
sample size for a given power.The formula used for calculating power and sample size n is: 
!-l x - !-l y r;;-
Zpower = () ~~ -Za/2 
Determining Sample Size: Balancing Power, Precision, and Practicality (2008). Patrick Dattalo, 
Oxford University Press 
For the above formulas r was the ratio of larger group to smaller group. 
Intima-media thickness between Genders 
~ 
o 
0.. 
0.0525 
0.0520 
0.0515 
0.0510 
0.0505 
0.0500 
o - Std DeIFO.0555 o ------- Std DeIFO.058 
o 100 200 
Total Sample Size 
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300 400 500 
Distensibility between Genders 
0.9 o -- Std De1F0.00213 o ------- Std DeIF0.00177 
0.8 
0.7 
0.6 
~ 0.5 
11. 
0.4 
0.3 
0.2 
0.1 
0 
0 100 200 300 400 500 
Total Sample Size 
Intima-media thickness between obese and non-obese 
1.0 
0.9 
0.8 
0.7 
~ 0.6 
11. 
0.5 
0.4 
0.3 
0.2 
0.1 
o 100 200 300 400 500 
Total Sample Size 
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Distensibility between obese and non-obese 
~ 
o 
0.. 
1.0 
0.8 
O.B 
0.4 
0.2 
o - Sid De\F0.00193 o ....... Sid De\F0.00115 
o .~--------------r-------------.--------------r-------------'r-------------~ 
o 100 200 300 400 500 
Tolal Sample Size 
Intima-media thickness between BP groups 
0.7 o - Sid De\FO.OB o ....... Sid De\F0.05 
O.B 
0.5 
0.4 
~ 
0.. 
0.3 
0.2 
0.1 
0 
0 100 200 300 400 500 
Tolal Sample Size 
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Distensibility between BP groups 
1.0 o -- Std Dev=0.0019 o ------- Std Dev=0.0024 
0.8 
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o 
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Appendix 7 
Raw Data 
serialno Group LabFieldAveS LabFieldAveD LabFieidMAP labasbp labadbp labamap FinapresAdjPP trueage gender Iheight Iweight 
Al048 0 92.5 52.67 65.94 95.22 53.48 67.39 41.74 11.85 0 150 39.4 
Al067 0 87.17 46 59.72 109.04 63.3 78.55 45.74 11.65 0 149.3 42.4 
A1127 0 87.67 51.83 63.78 101.93 52.96 69.28 48.97 12.7 0 161 42.9 
A1138 
A1141 
A1291 
A1365 
A1408 
A1441 
A148 
A1497 
A1543 
A1565 
A1570 
A1602 
A1622 
A1673 
A281 
A329 
A490 
A492 
A609 
A61 
A661 
A687 
A693 
A728 
A759 
A871 
A872 
A886 
A890 
Bl078 
o 
o 
o 
o 
o 
o 
o 
1 
o 
o 
o 
o 
o 
o 
1 
o 
o 
o 
o 
o 
1 
o 
o 
1 
o 
o 
1 
o 
o 
84.5 
93.67 
91.17 
93.5 
92 
86 
97.67 
113.5 
88.33 
94.67 
92.83 
86.83 
97.5 
95.67 
107.17 
99.5 
89.83 
88.67 
93.83 
86.67 
109.67 
81.67 
86.67 
115.33 
88.5 
90.5 
98.83 
85.5 
97.67 
108.17 
48.67 
57.17 
59.33 
57 
53.17 
54.67 
57.67 
72.33 
47.83 
61.33 
56.83 
49.17 
54.83 
48.5 
69.83 
60.5 
51.67 
55 
58.5 
51 
76.17 
53 
52.67 
74.33 
55.17 
54 
64 
55.67 
62.83 
65.5 
60.61 95.49 53.98 67.82 
69.33 106.46 72.2 83.62 
69.94 103.57 80.71 88.33 
69.17 89.6 54.04 65.89 
66.11 125.63 71.54 89.57 
65.11 103.66 66.01 78.56 
71 98.39 64.14 75.56 
86.06 124.04 54.58 77.73 
61.33 104.17 52.05 69.42 
72.44 95.36 59.17 71.23 
68.83 102.55 63.83 76.73 
61.72 115.63 63.11 80.61 
69.06 109.05 63.1 78.42 
64.22 114.11 58.92 77.32 
82.28 109.35 67.76 81.62 
73.5 119.5 58.45 78.8 
64.39 112.81 54.89 74.19 
66.22 109.02 66.64 80.77 
70.28 111.87 61.42 78.24 
62.89 95.14 57.01 69.72 
87.33 137.28 73.04 94.46 
62.56 91.98 50.87 64.58 
64 111.59 52.39 72.12 
88 115.94 60.13 78.73 
66.28 100.57 48.68 65.97 
66.17 104.49 50.21 68.31 
75.61 113.26 60.28 77.94 
65.61 102.37 63.17 76.24 
74.44 92.35 57.25 68.95 
79.72 112.73 62.77 79.42 
78 
41.5 13.85 o 149.1 36.1 
34.26 14.01 o 160.2 66 
22.86 14.34 o 169.1 52.2 
35.56 13.33 o 156.1 40.6 
54.09 12.63 o 166.8 49.6 
37.64 13.14 o 155.5 50.8 
34.25 12.67 o 151.3 40.7 
69.46 12.51 o 157.4 90.3 
52.12 13.56 1 173.8 51.7 
36.19 12.3 o 155.5 40.2 
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